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Development of Novel Biocompatible Hydrogel Coatings
for Implantable Glucose Sensors
Chunyan Wang
ABSTRACT
Due to sensor -tissue interactions, currently none of the commercially available
glucose sensors are capable of continuous, reliable monitoring of glucose levels during longterm implantation. In order to improve the lifetime of implanted glucose sensors, two series
of biocompatible novel hydrogel coatings were designed, synthesized and the physical
properties were measured.
Different hydrogels with various 2,3-dihydroxypropyl methacrylate (DHPMA)
compositions were coated onto glucose sensors. Results show that the higher freezable water
content, swelling rate and uniform porosity that resulted from high DHPMA content
increased the sensitivity and shortened the response time of glucose sensors. The linear
range of a glucose sensor coated only with hydrogel is short, however, the range can be
improved by coating the epoxy- polyurethane (PU) with a layer of hydrogel. Since the
hydrogel minimizes the fibrosis and inflammation, it shows promise for use in implantable
glucose sensors. However, the in vivo experiment shows only 25% of sensors still worked
after 4 weeks. In order to overcome problems present in the first series of experiments,
another series of novel hydrogels with various N-vinyl pyrolidone (VP) contents was
developed. This study has provided a feasible approach to design and select the properties
xviii

of the copolymer for coating implantable biosensors. The in vivo experiments demonstrate
that a hydrogel coating significantly improved the performance of implanted glucose sensors.
In order to suppress the acute inflammation caused by the surgery, dexamethasone-21
phosphate disodium salt (DX-21) was incorporated to a series of poly (HEMA-DHPMA-VP)
hydrogels to investigate the drug delivery in vitro. All hydrogels showed a high initial
release, followed by slow, long term release during the next hours to days. This release
pattern is believed to be optimum for implanted glucose sensors suppressing the acute and
chronic inflammation.
Water structures in hydrogels swollen in different media water, PBS and DX-21
solution were also investigated. 1HEMA:1DHPMA copolymer and VP-HEMA-DHPMA
copolymers imbibed higher freezable water fractions in DX-21 solution. The ratio of
transporting water mass to DX-21 mass is 9.6 which is independent of the hydrogel
composition.

xix

CHAPTER 1
INTRODUCTION
The aim of this project is to design, synthesize and characterize novel
biocompatible hydrogels for the coatings of implantable glucose sensors and drug
delivery system to enhance implanted glucose sensors’ function and lifetime in vivo.

This project has been funded by the National Institute of Health (NIH).

The

research has been conducted under the supervision of co-PI, Dr. Julie Harmon of the
Department of Chemistry (USF).

1.1. Diabetes

Diabetes is a chronic disease which involves regulatory problems with the
hormone insulin.

Insulin is released from the pancreas to regulate the amount of

glucose in the bloodstream.

When the pancreas doesn’t produce the correct level

insulin, or the body does not respond appropriately to insulin, the symptoms of
diabetes occur. According to American Diabetes Association (ADA), there are 23.6
million children and adults in the United States, or 7.8% of the population, who have
diabetes. (Diabetes, Oct.20, 2008)

There are two types of diabetes. Type 1 diabetes occurs when the
insulin-producing cells of the pancreas (called beta cells) are destroyed by the
1

immune system. People with type 1 diabetes don’t produce insulin and must use
insulin injections to control their blood glucose level.

It is estimated that 5-10% of

Americans who are diagnosed with diabetes have type 1 diabetes. Unlike people
with type 1 diabetes, people with type 2 diabetes produce insulin.

However, the

insulin their pancreas secretes is either not enough or the body is unable to recognize
insulin and use it properly.

When there isn't enough insulin or the insulin is not used

as it should be, glucose can't get into the body's cells. About 90 to 95% people with
diabetes have type 2 diabetes. (Diabetes, Oct.21, 2008)

Long-term high glucose levels can cause a number of long-term, sometimes
life-threatening complications including heart disease and stroke, high blood pressure,
blindness, kidney disease, nervous system disease, dental disease; therefore it is
crucial to control and monitor the blood glucose level.

1.2. Implantable Glucose Sensors
In order to regulate the blood glucose concentration, it is important for
diabetics to have the ability to monitor blood glucose concentration.

Diabetes

patients are used to self-monitoring blood glucose levels by finger pricking to obtain
blood samples. This kind of monitoring is discontinuous since it depends on how
frequently the blood glucose detection is performed.

It is very difficult to record

frequent enough determinations every day because the patients are unwilling to
withstand the pain associated with frequent finger pricking.

Currently, continuous

glucose monitoring systems, glucose sensors, are being developed as an alternative to
2

the present method.

Glucose sensors can continuously detect changes of blood

glucose levels, and therefore provide information on how to optimize insulin therapy
and to control the patients’ metabolism.
Since the first enzyme electrode was constructed for the measurement of blood
sugar in the 1960s (Clark et al. 1962), considerable amount of research has been
devoted to the development of glucose sensors. Many kinds of glucose sensors have
been studied including non-invasive glucose sensors such as optical glucose sensors
or sensors designed to detect the glucose concentration in tears (Baca, 2006) or urine
(Shieh, 1997), mini-invasive glucose sensors which can be implanted in the
subcutaneous tissue, vascular bed(Armour et al. 1990; Frost and Meyerhoff, 2002) or
transferring interstitial fluid outside the body and detecting by micro dialysis
device(Steinkuhl et al. 1996).

A non-invasive glucose sensor is the most optimum

method for patients and because it overcomes the biocompatibility problems.
However the precision of this method needs to be improved for clinical applications.
Micro dialysis needs recalibration at least once daily and has the time lag between 5
and 45 min caused by the length and diameter of the tube and the rate of the pumping.
Due to the risk of inserting the glucose sensor in the intravascular compartment for a
long period, most studies have focused on the development of needle-type glucose
sensors for subcutaneous glucose monitoring (Chen et al.1992; Matthews et al. 1988).

3

Figure 1.1 Schematic diagram of the sensor. Figure adapted from
(Moussy et al.1993)

4

Figure1.1 shows the typical needle-type implantable glucose sensor which is a
two electrode system including a central platinum (Pt) anode as working electrode and
a silver/ silver chloride(Ag/AgCl) reference electrode surrounding around Pt anode.
Glucose oxdiase(GOx) is immobilized between the coiled Pt electrode. The entire
sensor is coated with a Nafion membrane to protect other components from biological
degradation. Once glucose passes through Nafion membrane, in the presence of
oxygen, it is oxidized by GOx and produces hydrogen peroxide (H2O2). Hydrogen
peroxide is oxidized by a polarization voltage of about +700 mV at Pt electrode
surface, thus producing an electric current that is monitored (Abel and von Woedtke,
2002). The chemical reactions are:

GOx
Glucose +O2

H2O2

Gluconic Acid+H2O2

700mV

2H+ + O2 + 2e-

In vitro and animal experiments initially showed encouraging results. However the
long-term stability of the signal is insufficient due to the low biocompatibility of the
electrode surface.

1.3. Biocompatibility of Implanted Glucose Sensors
The implanted glucose sensors are not reliable if they progressively lose
function after several days in vivo.

It is believed this is caused by the events that

affect the sensor itself (e.g. degradation, fouling), as well as by changes in the tissue
surrounding the sensor, caused by implantation (Moussy, 2000).
5

When glucose sensors are implanted within the body membrane, biofouling
processes start immediately.

Low molecular weight solutes, such as ions, small

organic molecules, and high molecular weight composites, such as proteins and
enzymes, will deposit on the surface of the sensors. Surface deposition of the low
molecular weight solutes on the metallic electrodes, such as Pt, can cause degradation
or corrosion of the metallic component. These problems can be avoided by coating
electrodes with polymers such as polyurethane, cellulose and cellulose acetate, and
Nafion. The initial step of protein adsorption could result in an unstable protein
layer, which may alter or totally block the substrates’ transportation, and therefore
diminishing sensor’s in vivo performance. Once a protein layer has formed, cellular
interactions occur with protein coated sensors shown in Figure1.2 (Fraser, 1997).
These interactions lead to adhesion and activation of cells which characterize the
inflammatory response.

In such a case the diffusion distance of the glucose and

oxygen is greatly increased, and the true glucose concentration surrounding the
implantation site is different from that in non-inflammed subcutaneous tissue (Rebrin
et al. 1992). Pickup et al. (Pickup et al. 1993) reported protein and cellular
accumulation on the tips of the non-functioned glucose sensors after only five hours
of implantation.

Figure1.3 shows scanning electron microscopy (SEM) Photographs

of Tips of Glucose Sensors. The functioning sensor shows minimal biofouling, but
the non-functioning sensor shows significant protein and cellular accumulation.

6

When substances from the body are able to penetrate the outer membranes and
alter the metal electrode surface, electrode fouling, sometimes referred to as electrode
passivation, occurs and causes a decrease sensor signal(Reddya and Vadgamab, 1997;
Linke et al. 1999).
In the case of fibrosis, the smooth solid sensors become surrounded by the
fibrous capsule. The fibrous capsule surrounding the sensor presents a structurally
distinct barrier of collagen fibrils, which might have an effect on the substrate mass
transport, resulting in a delay in sensor response and an underestimation of analytes.
(Frazer, 1997) Figure1.4 shows dense fibrous capsule tissue surrounding a glucose
sensor tip after 10 days of implantation in subcutis (Ertefai and Gough, 1989).

Figure1.2 The initial protein adsorption is followed by cellular adhesion onto the
protein-coated surface of the device. Figure adapted from (Voskerician and Aderson,
2006)

7

Figure1.3 SEM photographs of tips of glucose sensors. (A) Control sensor not
implanted; (B) Functioning sensor showing minimal biofouling; (C) Non-functioning
sensor showing significant protein and Cellular accumulation. Figure adapted from
(Pickup et al. 1993)

8

Figure1.4 Light micrograph image of glucose sensor tip after 10 Days of
implantation in subcutis. Figure adapted from (Ertefai and Gough, 1989).

9

1.4. Strategies to Improve Sensor Biocompatibility
It can be seen that modification of the interface between sensor and tissue to
control inflammation and fibrosis will enhance a glucose sensor’s biocompatibility,
function and lifespan.

Thus strategies to improve sensor biocompatibility include

modifications to reduce protein adsorption and local drug delivery of tissue response
modifiers.
Modifications to Reduce Protein Adsorption
Protein adsorption is controlled by the characteristics of the material including
topography, charge density, distribution and mobility, surface groups (chain length,
hydrophobicity, and hydrophilicity), structural ordering (soft to hard segment ratio
and distribution), and the extent of hydration(Wisniewski et al.2000), therefore the
simple strategy to improve sensor biocompatibility is to reduce protein adsorption by
surface modification. One approach to modify the surface of glucose sensors is to
incorporate poly (ethylene glycol) (PEG) into a poly(hydroxyethylmethacrylate).
The PEG chains tend to line up parallel to each other and perpendicular to the surface
to present a water rich phase that resists penentration by many proteins (Claesson,
1993). Compared to the same membranes without PEG, PEG in the outer membrane
induced less fibrous encapsulation after subcutaneous implantation in rats.

But there

is no report about improvement in sensor performance (Quinn et al. 1995; Quinn et al.
1997).
The diamond-like carbon (DLC), so-called ―inert‖materials are also used to
coat on glucose sensors to enhance hemocompatibility as determined by both
10

sensitivity change and surface deposition of blood components examined by SEM.
(Higson and Vadgama, 1995).
Another strategy to reduce protein adsorption is to develop biomimetic
coatings containing phosphorylcholine (PC) groups.

It has been demonstrated that

PC coated glucose sensor could diminish protein adsorption (Yang et al. 2000).

One

example of making biomimic membrane is to self-assemble phospholipids on the
polymer surface containing a phosphorylcholine group, 2-methacryloyloxyethyl
phosphorylcholine (MPC) and hydrophobic alkyl group. The surface shows an
excellent resistance for both protein adsorption and blood cell adhesion.

The relative

output current of the sensor covered with this membrane was maintained as the initial
level even after 14 days of subcutaneous implantation in a rat (Ishihara, 2000).
Other methods to reduce protein adsorption include the use of alginate/ polyly-sine gel (Shichiri et al. 1988), PHEMA/polyurethane (PU)(Shaw et al. 1991),
NafionTM (perfluorosulphonic acid) membrane(Wilkins et al. 1995; Moussy et al.
1994), crosslinked albumin(Armour et al. 1990), cellulose(Kerner et al. 1993).
Local Drug Delivery Strategies
Site specific, controlled delivery of tissue response modifiers can be used
alone or combine with above surface modifications to help control the tissue reaction.
The anti-inflammatory drug dexamethasone (DX) contained in microspheres is
incorporated into a hydrogel and coated onto glucose sensors.

The in vivo

experiment results show that eluting dexamethasone successfully controled negative
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tissue reactions at the sensor-tissue interface by reducing the level of
inflammation-mediation cells to those observed in normal tissue (Patil et al. 2004;
Norton et al. 2005).
Controlled nitric oxide (NO) or vascular endothelial growth factor (VEGF) delivery
also can suppress the tissue reactions and improve biosensor performance(Norton et al.
2005; Shin and Schoenfisch, 2006).

1.5. Hydrogel
Hydrogels are three- dimensional cross-linked polymer networks which are
designed to swell but not dissolve in water.

They can be chemically cross-linked by

a covalent bond with multi-functional cross-linkers or physically cross-linked by
physical cross-links from entanglements, association bonds such as hydrogen-bond,
Van der Waals forces, hydrophobic forces or crystalline forces (Peppas, 1986, V1).
Due to high water absorption, low interfacial tension, high permeability to
small molecules, and the soft and rubbery nature, hydrogles are well suited for
biomaterials. Therefore, the biomedical applications of hydrogels, such as sutures,
contact lenses, and drug delivery vehicles are of most interest.

Table 1.1 lists some

biomedical applications of hydrogels summarized from Peppas’Book (Peppas, 1986).
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Table 1.1 Some biomedical applications of hydrogels
Biomedical
Example Materials
applications
Poly(vinyl alcohol)(PVA), Polyacrylammide(PAAm),
Blood compatible

Poly(N-vinylpyrolidone)(PVP),Poly(hydroxyl-methacrylate)(P

applications

HEMA), poly(ethylene, oxide)(PEO), Poly(ethylene
glycol)(PEG), cellulose
PHEMA, P(VP-co-HEMA), acrylamide and acrylonitrile

Contact lenses
based hydrogels, P(HEMA-co-MMA)
Artificial tendons

Fiber (polyethylene terephathalate) reinforced hydrogel
PHEMA, P(HEMA-methyl acrylate) copolymers,

Controlled release
P(HEMA-MMA)copolymers, P(HEMA-polymethacrylic acid)
devices
copolymer, PVA, PVP,
Membranes for
biomacromolecular
separations for

P(glycerolmethacrylate-co-MMA),P(Hydroxypropyl

plasmapheresis,

methacrylate -MMA), pure PHEMA, PVA, PVP

artificial kidneys,
artificial liver
sutures

PHEMA

Artificial skins

PVA-formaldehyde foam, PHEMA
13

Hydrogels commonly are classified into neutral hydrogels, ionic hydrogels and
swollen interpenetrating polymeric networks (IPN).

Neutral hydrogels are based on

neutral monomers, while ionic hydrogels are based on the ionic monomers such as
acryl acid, methacrylic acid.

An interpenetrating polymer network (IPN) is a

combination of two polymers one of which must be synthesized, or crosslinked in the
immediate presence of the other.

For an interpenetrating polymeric network (IPN)

hydrogel system, there is no chemical bonding between two polymer networks, but
there are physical entanglements (Liu et al. 2003 ).

Covalent crosslinked gels do not

dissolve in organic solvents even upon the addition of heat; whereas non-covalent
crosslinked gel will eventually dissolve in solvents or melt upon the addition of heat
(LaPorte, 1997). Thus physically crosslinked gels are not stable in heat and solvent
environment.

The properties of synthetic hydrogels can be controlled by chanaging

the ratio of hydrophilic to hydrophobic monomers.

Neutral hydrogels are more

biocompatible than the ionic hydrogels since more proteins will absorb on the surface
of ionic materials (Peppas,1986), and crosslinked neutral hydrogels are more stable
than the interpenetrating hydrogels.

In this project the neutral hydrogels are

polymerized for the sensor coatings because the nonionic hydrogels exhibit minimal
protein build-up and excellent pH stability (Gates and Harmon, 2001).
Some common synthetic hydrogels being used as biomaterials include
PHEMA, poly(2,3-dihydroxypropyl methacrylate) (PDHPMA)), PAAm, PVP, and
PVA.
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Poly(hydroxyalkyl methacrylates)(PHEMA) Hydrogels
PHEMA is the most studied hydrophilic polymer in the biomedical industry.
Since Wichterle and Lim polymerized HEMA hydrogels in 1960(Wichterle and Lim,
1960) for contact lenses, PHEMA hydrogels have received a lot of interest.
The biocompatibility of PHEMA hydrogels is primarily due to high water
content absorbed into the hydrogel network.

Initiators, reaction by-products,

residual monomer, and impurities can be extracted with successive aqueous washings,
so the likelihood of toxic or local immune reactions decreases in biomedical
applications.

When used as an implant, the rubbery nature of the hydrated hydrogel

reduces mechanical irritation of surrounding tissue.

The low interfacial tension

between the hydrogel surface and aqueous solution minimizes protein adsorption and
possibly cell adhesion (Ratner and Hoffman, 1976).
Cross-linker impurities are present in all methacrylate monomers, so it is usual
to obtain crosslinked gel instead of linear PHEMA.

PHEMA hydrogels can be

prepared by bulk polymerization or solution polymerization using heat initiators or
photoinitiators.

The most popular method for preparing PHEMA hydrogels is by

solution polymerization of the monomer, HEMA, in the presence of a cross-linking
agent.

Different solvents can be used for solution polymerization such as dimethyl

sulfoxide(DMSO), propanol, glycerol, ethylene glycol, cyclohexanol, toluene, and
dimethyl formamide.

Water is commonly used as a solvent in the preparation of

PHEMA hydrogels.

Below a critical solvent concentration (40 to 60% water by
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weight), the gel thus formed is homogeneous, nonporous, and optically transparent.
When the solvent concentration is above this critical value, the resulting gel is
heterogeneous and has a macro-porous structure, and is optically opaque (Laporte,
1997).
The water content of PHEMA hydrogels is usually relatively low(<45 wt%),
which results in the limited applications of these hydrogels (Lee and Lin, 2003).
Furthermore, PHEMA does not have the stringent mechanical properties needed for
many biomedical applications. It was found that mechanical properties could be
improved by crosslinking with ethylene glycol dimethacrylate(EGDMA).

Water

content can also be increased by copolymerizing with other monomers such as DHPM
or vinyl monomer, VP (Laporte, 1997). (Table 1.2)
Poly(N-Vinyl-2-pyrolidone)(PVP) Hydrogels
The backbone and ring structure of PVP provide hydrophobicity while the
highly polar amide group provides hydrophilicity similar to that of a protein, but is
physiologically inactive.

The size of VP repeating structure along the main carbon

chain produces free volume in the material, resulting in flexibility and water solubility.
PVP was first used as a blood plasma substitute and extender during World War II
(Robinson et al. 1990) VP can also be copolymerized with other materials to modify
properties for various medical applications (Laporte, 1997). PVP is a major
component of some contact lenses and has been proposed as a material that can
enhance blood compatibility (Francois et al. 1996).
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PVP hydrogels have also been used as cell culture substrates.
Interpenetrating polymer networks (IPNs) composed of PVP and gelatine have been
studied as non-fouling materials for devices in contact with blood (Lopes and
Felisberti, 2003).

It has been shown that 70% PVP exhibits optimum swelling

degree and compression strength.

In biocompatibility tests, 70%PVP hydrogels

showed no deleterious effect to the cells but were not good as gelatin for cell growth.
As it turns out, 50% PVP retains the best properties of both polymers with higher
water swelling degree, compression strength and biocompatibility.

Risbud et al.

(Risbud et al. 2000) reported a growth promoting effect in a PVP-co-chitosan (a linear
polysaccharide) hydrogel as compared to chitosan gels alone.

Janson et al. studied

porous VP-BMA (n-butyl methacrylate) copolymers as scaffolds for bone tissue
engineering.

In their study they reported that 50:50(VP: BMA) is less cytotoxic and

more biocompatible than 70:30 counterpart in vivo (Janson et al. 2005).

From these

research results, it can be concluded that VP can enhance the water content,
mechanical properties and porous structures of hydrogels at the same time, behavior
unusual for a hydrogel.

High VP percent hydrogels show less biocompatibility, but

50% of PVP hydrogels are biocompatible.

Furthermore, PVP can be coated on the

polyurethane surface and firmly attach to the surface (Francois et al. 1996).
property is essential for this project.
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This

Table 1.2 monomers’ structures and MWs
Chemicals

Structure

Molecular Weight
O

2-hydroxyethyl
methacrylate(HEMA)

CH2

C

130.14

C
CH2

CH3

O

CH2

OH

O

2,3-dihydroxypropyl
methacrylate(DHPMA)

CH2

C

C

CH3

O

CH2
CH

160.17

CH2
OH

OH

N-Vinyl-2-Pyrrolidinone(V
P)

111.14

Ethylene
dimethacrylate(EGDMA)

198.22

1-phenyl-2-hydroxy-2-meth
yl-propan-1-one (Benacure
1173)

O

CH3

C

C
CH3
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OH

164.00

Poly (2,3-dihydroxypropyl methacrylate) (PDHPMA)) Hydrogels
In comparison with PHEMA, PDHPMA is more hydrophilic and even soluble
in water since it contains two hydroxyl groups in each of its repeat units (Hou et al.
2002). DHPMA is often copolymerized with HEMA or VP to make hydrogels for
soft contact lenses (Wang et al. US patent).

Clinical experiments show that

hydrogels used as contact lenses will dehydrate especially at high water contents
(McConville and Pope, 2001).

Gates found that DHPMA exhibits decreased water

loss rate (Gates et al. 2003).
Photopolymerization of Hydrogel by Ultraviolet light (UV)
Polymerization of hydrogels can be initiated by γ radiation, heat or Ultraviolet
(UV) radiation with initiators or they can self-initiate.

UV radiation is frequently

used to induce cross-linking of polymers, because it requires less time, less energy,
and generates little heat during polymerization (Laporte, 1997).

In addition, heat

sensitive substrates such as plastics, printed circuit boards, paper, and wood can be
coated and cured by UV (Nichols et al. 2001; Koleske, 2002).
There are three main components in UV curing system: monomers or
oligomers, photo-initiators and additives.

First, photo-initiators absorb high intensity

UV light and are raised to an excited state. From their radiation-excited state, the
photo-initiators photolyze or degrade directly or indirectly into free radicals.

These

free radicals initiate the very rapid polymerization and crosslinking of monomers (Lee
et al. 2006).

Steps of UV polymerization are listed in Figure 1.5.

19

According to the process for forming the initiating radicals, photo-initiators
can be divided into two classes.

Norrish Type I photo-initiators (cleavage) photolyze

through a homolytic fragmentation mechanism or through a-cleavage, and thereby
directly form free radicals capable of initiating polymerization. (Figure1.6)
Norrish Type II photo-initiators (H-abstraction) are activated with radiation
and form free radicals by hydrogen abstraction or electron extraction from a second
compound (coinitiator) that becomes the actual initiating free radical.

In addition,

the Norrish Type II reactions are intra-molecular, so Type II photo-initiators are more
easily affected by the environment such as oxygen and viscosity (Lee et al. 2006).
The majority of Type I photo-initiators are aromatic carbonyl compounds
which can carry out fragmentation by α-cleavage or β-cleavage.

The most important

fragmentation in photo-initiator molecules is the α-cleavage of the carbon-carbon
bond between the carbonyl group and the alkyl residue in alkyl aryl ketones
(Figure1.7). 1-phenyl-2-hydroxy-2- methyl- propan-1-one (Benacure 1173) is a very
popular photo-initiator (structure shown in Table 1) because it is highly reactive,
thermally stable, does not yellow and can be used in water based formulations
(Crivello and Dietliker, 1998).
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hv

PI

PI*

photoreaction

photoinitiation
PI*

R1. + R2.

Kd

R1. + M

M. + M

R1

MM + nM

Mn. + R3

H

thermal reaction
R3. + M

R1
R1

Mi.

Mn. + R2.

Mn. + R1

Mi.

Ktd

H + R3.

Mn

chain transfer

M.
R1

Ktr
Ktr'

Mn.

R1

Kp

R3

Ki'

Mn. + R1

R1

propagation

R1

Kha

MM.

R1

Kp

.

R1
R1

M.

R1

Ki

R1
R1

Mn+i.
Mn
Mn'

R1
R2

+ R1

termination
Mi'

designation of rate constant

PI=photoinitiator
PI*=excited photoinitiator

Kd=dissociation

R1.,R2.=radical fragments of the photoinitiator

Ki=initiation

R3-H=hgydrogen donor

Kp=polymerization
Kha=hydrogen abstraction

M=monomer

Ki'=initiation by chain transfer radical
Ktr=termination by recombination of
growing polymer chains
Ktr'=termination by recombination
Ktd=termination by disproportionation
with primary radicals

Figure1.5 Various steps in a photoinitiated polymerization
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PI

hv

unimolecular reaction
(fragmentation)
PI*

photoinitiator excited photoinitiator

R1. + R2.
free radicals

Type I Photoinitiator: unimolecular fragmentation

PI

hv

biomolecular reaction
PI*

+

photoinitiator excited photoinitiator

COI
coinitiator

R1. + R2.
free radicals

Type II photoinitiator: bimolecular fragmentation
Figure1.6 Types of photoinitiator. (Crivello and Dietliker, 1998)
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X
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R2

R1
C

O

R1

C

C

S
X

ISC
R3

R2

T
X
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a-cleavage
R1, R2=alkyl, aryl
X=O, NR2
S= Singlet

O

T= Triplet

C. +

R3

ISC= Intersystem crossing

R1
.

C

X

R2

Figure1.7 α-Cleavage of alkylaryl ketones.(Crivello and Dietliker, 1998)

Previous investigations into the biocompatibility of PHEMA and PDHPMA as
homo- and copolymers by UV polymerization showed that hydrogels containing
80%DHPMA and 20%HEMA were found to induce minimal to no fibrosis when
implanted subcutaneously in rats (Mohomed et al. 2006).

Unfortunately, as it sorbed

large amounts of water, the mechanical stability of the high content DHPMA
copolymers (80%DHPMA:20%HEMA) and the PDHPMA homopolymer decreased,
and the samples were easily fragmented.

The biocompatible hydrogels were also

coated onto the polyurethane (PU)/epoxy coated metal sensor by dip-coating, or in
situ polymerization.

It was noted that the PHEMA coating easily delaminated from

the PU/epoxy coating once swollen in water (Mohomed, 2006).
To improve the lifespan of glucose sensors, the objectives of hydrogel
coatings are:
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1) the coating must allow glucose, oxygen and hydrogen peroxide to diffuse
freely, while causing minimal fibrosis and inflammation.
2) it should be easily coated onto the surface of implantable glucose sensors
3) it should attach firmly and permanently to the glucose sensors and strong
enough not to break during the implantation period.
4) it must not deter the performance of the implantable glucose sensors.
5) it should deliver anti-inflammatory drug and release drug to suppress both
acute and chronic inflammatory.
According to previous work by Mohomed, the formulations of hydrogel have
based on HEMA and DHPMA copolymer for its excellent biocompatibility, but well
modified with another monomer to improve the coating properties.
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CHAPTER 2
SYNTHESIS AND PEFORMANCE OF NOVEL HYDROGELS COATING
FOR IMPLANTABLE GLUCOSE SENSORS
2.1. Introduction
State of the art implantable glucose sensors do not work reliably and have a
short life after implantation (Moussy，2002).

This in vivo loss of function is caused

by tissue reactions surrounding the sensor such as fibrosis and inflammation (Mang et
al. 2005).

In order to improve the lifetime of implantable glucose sensors, the

biocompatibility of the coatings must be monitored (Gerritsen et al. 2000).

Many

biocompatible coatings have been prepared for sensors such as hydrogels (Praveen et
al. 2003; Galeska et al. 2001; JP 60171140; USP 5786439), silica-based hybrid
materials(Kros et al. 2001), sol-gel coatings(Gerritsen et al. 2000), diamond-like
carbon films and diamond-like carbon-coated anodized aluminum oxide nanoporous
membranes(Narayan et al. 2007). All of these coatings showed some potential for
use in sensors, but formulations need to be optimized at this time.
The outer interfacial coatings of implantable glucose sensors must be stable in
biological fluids, ensure the transport of glucose to the sensors, resist the deposition of
the proteins and other interferents and minimize fibrous encapsulation. Threedimensional cross-linked polymer networks known as hydrogels have been shown to
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meet these requirements and have the added benefit of swelling in water without
dissolving (Praveen et al. 2003; Kros et al. 2001;Gerritsen et al. 2000).
Poly(hydroxyethyl methacrylate) (PHEMA) hydrogels were first polymerized
and studied for biological use by Wichterle and Lim in the early 1960s(Wichterle and
Lim, 1960;Wichterle and Lim, 1961).

Since they are biocompatible, PHEMA

hydrogels have been used in biomedical and pharmaceutical applications such as
contact lenses, implants and drug delivery systems.

PHEMA was first used in

glucose sensors by John Christopher, et al in 1990(Pickup and Claremont, 1990).
Sensors coated with PHEMA were stable for 24hrs in vitro at 37℃.

However, much

longer life times are required. PHEMA hydrogels are clear, exhibit smooth surfaces
and are biocompatible (Rozakis et al. 2005). Drawbacks of using PHEMA gels are
that their mechanical properties are poor and equlibrium water contents are relatively
low, <45 wt% (Lee and Lin, 2003); water uptakes of 200 wt% are needed for
optimum operation (Van Antwerp et al. 1998). Mechanical properties can be
increased by preparing PHEMA hydrogels with ethylene glycol dimethacrylate
cross-linker(EGDMA). Equilibrium water contents can be increased by preparing
PHEMA hydrogels with more hydrophilic monomers such as 2, 3-dihydroxypropyl
methacrylate (DHPMA) (Yasuda et al. 1966; Macret and Hild, 1982) or N-vinyl
pyrolidinone (VP) (Laporte, 1997). According to previous investigations of hydrogel
(80%DHPMA:20%HEMA) coating for implantable glucose sensors, it was found that
the biocompatibility and equilibrium water content are improved (Mohomed. 2006).
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Unfortunately, as it sorbed large amount of water the mechanical stability of the high
content DHPMA copolymers (80%DHPMA: 20%HEMA) decreased, and the samples
were easily fragmented. The biocompatible hydrogels were also coated onto the
polyurethane (PU)/epoxy coated metal sensor by dip-coating, or in situ
polymerization. It was noted that hydrogel coatings easily delaminated from the
PU/epoxy coating once swollen in water (Mohomed, 2006).
Since PVP was first used as a blood plasma substitute and extender during
World War II (Robinson et al. 1990), VP can be copolymerized with other materials
to modify properties for various medical applications (Laporte, 1997). VP can
enhance the water content, mechanical properties and porous structures of hydrogels
at the same time, behavior unusual for a hydrogel.

High VP percent hydrogels show

less biocompatibility, but 50% of PVP hydrogels are biocompatible (Lopes and
Felisberti, 2003; Risbud et al. 2000). Furthermore, PVP can be coated on the
polyurethane surface and firmly attach to the surface (Francois et al. 1996). This
property is essential for this project.
The goal of this study was to develop a novel hydrogel copolymer with
HEMA, DHPMA, VP and EGDMA which was facile to coat on the glucose sensors,
did not deter the detection of glucose and exhibits improved biocompatibility. In order
to optimize the compositions of hydrogels swelling, SEM and water structure of
hydrogels were characterized. Different formulations hydrogels were coated on the
implantable glucose sensors by UV curing. Glucose sensors used for this study were
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based on the long term excess enzyme loading coil-type implantable amperometric
sensors (Yu et al. 2005;Yu et al. 2006). In vitro and in vivo evaluations of the
hydrogel coated glucose sensors with and without PU were also undertaken.

2.2 Experimental Procedures
2.2.1 Materials.
2-Hydroxyethyl methacrylate (HEMA) and 2, 3-dihydroxypropyl methacrylate
(DHPMA) were donated by Benz R & D (Sarasota, FL，USA). They were used as
received without further purification. N-Vinyl-2-Pyrrolidinone (VP) (99.9+%) was
purchased from Sigma-Aldrich Co.( St. Louis, MO, USA) and purified by vacuum
distillation to obtain a colorless liquid according to reference(Jansen et al. 2005).
Ethylene glycol dimethacrylate (EGDMA), glucose oxidase (GOX) (EC 1.1.3.4, Type
X-S, Aspergillus Niger, 157,500U/g), benzoic acid, gentamicin, ATACS5104 epoxy
adhesive, Fluka Selectophore® 81367 polyurethane (PU) and tetrahydrofunan (THF)
were

obtained

from

Sigma

-Aldrich

1-phenyl-2-hydroxy-2-methyl-propan-1-one

Co.(St.Louis,

(Benacure

1173)

MO,
from

USA).
Mayzon

Corporation (Rochester, NY, USA) was used as received. Dextrose (D-glucose),
bovine serum albumin (BSA), and glutaraldehyde (50%) were obtained from Fisher
Scientific (Pittsburgh, PA).  0.125 mm Teflon-covered platinum-iridium (9:1 in
weight) and silver wires were obtained from World Precision Instruments, Inc.
(Sarasota, FL，USA). High temperature mini round glue sticks were supplied by
Adhesive Tech (Hampton, NH, USA). Hematoxylin and eosin were obtained from
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Fisher Scientific (Pittsburgh, PA) and trichrome stains were purchased from
Newcomer Supply (Middleton, WI).
2.2.2. Synthesis of Poly (HEMA-DHPMA-VP-EGDMA) Hydrogel Series
Various molar ratios of HEMA and DHPMA were weighed and mixed in 20
ml glass vials. 9 mol % of VP, 1 mole% EGDMA and 1.5 mol% initiator Benacure
1173 were added to the solutions (Table 2.1).

The solutions were diluted 1:1 with

distilled water. After deoxygenation with argon gas, the solutions were injected into
hand made glass cells measuring 55mm  25mm  1mm. The sides of the cells were
secured with a glue gun.

The solution filled cells were placed under a UV lamp

(Spectronics Corporation, Westbury, NY, USA) at a wavelength of 254nm for 100min.
Argon gas was used to purge the system in order to minimize oxygen inhibition of the
reaction.

Transparent uniform sheets were obtained and these xerogels were swollen

in distilled water to yield hydrogels.

The water was refreshed every day for one

week to remove any unreacted monomers.
The hydrogels were freeze-dried for various studies using a Virtis
Freezemobile 12XL freeze dryer (The Virtis Company Inc, Gardiner, NY, USA) to
keep the pores inner morphology.
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Table 2.1 Feed compositions of synthesized xerogels
Mole%

HEMA DHPMA VP

EGDMA

DHPMA0

90

0

9

1

DHPMA20

70

20

9

1

DHPMA40

50

40

9

1

DHPMA60

30

60

9

1

DHPMA80

10

80

9

1

DHPMA90

0

90

9

1

2.2.3 Scanning Electron Microscopy (SEM)
The hydrogel samples obtained by the above method were cut and freeze-dried
to determine the inner morphology.

The morphology of the freeze-dried gels were

studied via a Hitachi Scanning Electron Microscope S-800 (Hitachi High
Technologies, Pleasanton, CA) with 20nm gold coating by a HummerX sputter coater
(Anatech, Ltd, Springfield, VA).

The working distance between the sample and

electron (WD) was 5mm with 25.0 kV.
2.2.4 Sorption Experiments
Hydrogel samples were cut with a 12mm diameter cork bore to obtain uniform
shapes.

All sheets were freeze-dried for one day and stored in a desiccator at room

temperature.

The sorption behavior of hydrogels was monitored by detecting the

increase in mass of the samples at different time intervals by Sartorius BP211D
balance (  0.01mg, Sartorius Corporation, Edgewood,NY, USA).

In a typical

sorption experiment, a pre-weighed dry gel sheet was immersed into water at 24±1℃
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in a Fisher Scientific Isotemp water bath (Pittsburgh, PA).

At a prescribed time

intervals the hydrogel was taken out of solution and weighed after wiping off the
excess water from the surface with Kimwipe paper (Kimberly-Clark Professional).
The sorption degree, SD, of hydrogels was defined as follows:
SD%=

Wt  Wd
M
 100= t  100
Wd
Wd

(2-1)

Where W d is the weight of the dry gel, Wt is the weight of wet hydrogel at each
time interval, and M t is the gain in the weight of the dry gel at time t.
The equilibrium water content (EWC) of the hydrogel was determined using the
following equation:
EWC%=

W  W d
M
 100=   100
W
W

(2-2)

where W and M  are the weight and weight gain of the swollen hydrogel at
equilibrium separately.
2.2.5 Differential Scanning Calorimetry (DSC)
All calorimetric data were obtained via a TA Instruments 2920 differential
scanning calorimeter (DSC, TA Instruments, New Castle, Delaware).

Nitrogen gas

was passed through the instrument at a flow rate of 70ml/min. Before measurement
the DSC was calibrated from -100℃ to 250℃ at a heating rate of 5℃/min with an
indium standard. All the sample masses for DSC ranged from 4mg to 10mg.
For the determination of glass transition temperature, samples were
freeze-dried for one day and kept in a desiccator.

The samples were quickly

weighed, sealed in aluminum pans, and immediately scanned from 30℃to 200℃.
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Samples were cooled and rescanned; the glass transition was determined from the
second heating cycle in order to minimize any aging effects.

The reported glass

transition temperature was determined as midpoint at half heat flow or heat capacity.
To measure the water structure of equilibrium swollen hydrogels, first samples
were cut and weighed accurately after wiping off the surface water with Kimwipe
paper and immediately sealed in Al pans. The DSC curves were measured heating
from -100℃ to 20℃ with a heating rate 5℃/min.

Endotherm areas were

determined.
2.2.6 Sensor Preparation
Hydrogel-coated glucose sensors used for this study were based on the
coil-type implantable sensor previously described (Yu et al. 2005; Yu et al. 2006).
The detail fabrication method of Pt/GOx and Pt/GOx/Epoxy-polyurethane base
sensors can be found in those papers. The coating process was achieved by applying
a ~ 0.4 µL of 50% hydrogel solution to either the enzyme layer or the
epoxy-polyurethane layer, using a 10 µL micropipette, and then curing under an argon
atmosphere and a 254 nm UV light for 100 min. Membrane surfaces were observed
and photographed using an Olympus BX41 microscope (Quantitative Imaging Co.,
Canada). The cured hydrogel coating was transparent and firmly attached to the
sensor as shown in Figure 2.1.
2.2.7 In vitro Evaluation Method
Electrochemical measurements were performed with Apollo 4000 4-Channel
Potentiostats (World Precision Instruments, Inc., Sarasota, FL).
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Newly prepared

glucose biosensors were conditioned in a 5mM glucose /PBS (NaCl 8.76g, KH2PO4
3.53g, Na2HPO4 3.40g, Benzoic acid 2g, water 10000ml) (ionic strength = ~ 0.16M)
for at least 2 hours and then continuously polarized at +0.7V vs. Ag/AgCl until a
stable background current was reached.

The response was determined as the time

needed for the sensor’s current to reach 90% of (T90%, min) the maximum current
when the glucose concentration changed from 5 mM to 15 mM.

The sensitivity (S)

was determined using a two-point method and can be calculated by
S (nA/mM) =

I 15mM  I 5 mM
10

(3)

where I15 mM and I5 mM represent the sensor response currents obtained in 15 mM
and 5 mM glucose solutions, respectively. The sensors for long-term observation were
stored in PBS. Calibration plots were obtained by stepwise adding 100 mM glucose
solutions to 8.0 mL PBS. All measurements were performed at 241C.
2.2.8 In vivo Biocompatibility Studies
The epoxy-PU coated Silastic tubing (Dow Corning, Midland, MI) ( = ~ 4
mm, length = ~ 50 mm), a DHPMA 80 bar ( = ~5 mm, length = ~50 mm), an
epoxy-PU coated glucose sensor and a DHPMA 80 coated glucose sensor were
implanted subcutaneously in rats for 28 days. The tissues surrounding the implants
were removed at day 28 and processed for histology with hematoxylin, eosin and
trichrome stains (Galeska et al. 2001).
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A

1 mm

B

D

C

Figure 2.1 Sensor photos show thin layers of hydrogel coating: A. hydrogel on
Pt/GOx sensor B. hydrogel on Pt/GOx sensor after swelling C. hydrogel on
Pt/GOx/Epoxy-polyurethane

base

sensors

Pt/GOx/Epoxy-polyurethane sensors after swelling
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hydrogel
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2.3 Results and Discussion
2.3.1 Preparation of Hydrogels Sheets and Coatings
A type I photoinitiator, Benacure 1173, undergoes unimolecular bond cleavage
upon irradiation in argon atmosphere.

It produced well cured samples, including the

thin layers used on the sensors (Lewis et al. 1975; Maillard et al. 1983). The water
present in the polymerization mixture minimized the heat of polymerization and
bubble-free samples were obtained. The amount of solvent in the reaction mixture did
not exceed the critical solvent concentration which would result in heterogenous
samples (Peppas, 1986).

In order to avoid producing bubbles and obtain the

homogenous transparent hydrogel, monomers were dissolved in water with the weight
ratio around 1:1.

Even if there was a little heat produced, it would diffuse readily,

and would not yield big bubbles inside the hydrogel.

In this work, homogenous

hydrogel sheets and coatings of implantable glucose sensor were obtained by UV
cured.
2.3.2 Inner Sample Morphology
The scanning electron micrographs shown in Figure 2.2 depict the dramatic
effect of DHPMA on morphology. The sample with no DHPMA exhibits irregular
pores.

At 20% DHPMA the number and regularity of the pores increase. This

trend increases up to 80% DHPMA. At 90% DHPMA the structure is less regular,
possibly due to the high swelling stresses which can induce tearing in the sample.
Coatings for implantable glucose sensors must effectively transport water, glucose
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Figure 2.2 SEM micrographs of inner gels (  350 magnification): D0,D20, D40, D60,
D80 and D90
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and oxygen. From the morphology of different gels it can be seen that 80% DHPMA
gives the most uniform, porous structure and therefore, might be an optimum
candidate for permeable sensor coatings.

2.3.3 Sorption Behavior
The sorption versus time profile is shown in figure 2.3.

Both the equilibrium

water content and the sorption rate increase with DHPMA content.
extra hydroxy group in DHPMA which increases the hydrophilicity.

This is due to the
It has also been

shown that increasing DHPMA content can slow the dehydration rate and increase the
rehydration rate of the sample (Gates et al. 2003; Pescosolido et al. 1990).

This is

ideal for the implantable glucose sensors, since dehydration reduces biocompatibility
(McConville and Pope, 2001).

It has been stated that glucose sensor coatings should

exhibit the equilibrium sorption degrees of over 120%, and, preferably over 200%
(Van Antwerp et al. 1998).

Figure 2.3 demonstrates that the 80% DHPMA, again, is

an optimum formulation for sensors.
The water diffusion coefficient can be easily calculated when diffusion
controls the transport process.

It is well known that sorption behavior in polymers is

quite complex (Harmon et la. 1988;Harmon et al. 1987).

At one extreme, Fickian

diffusion controls kinetics. However, since swelling involves segmental relaxation,
the relaxation rate can influence transport.

If the relaxation rate is slower than the

diffusion rate, relaxation can dominate transport kinetics.

In reality, sorption

behavior can range from pure Fickian behavior to pure relaxation behavior.
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In pure

Fickian behavior, sorption versus the square root of time curves are linear up until
about 60% of the equilibrium water content is imbibed (

Mt
≤0.6). When relaxation
M

dominates transport, sorption is linear with respect to time. The extent of influence
from Fickian diffusion and relaxation is characterized by the time exponent in the
following equation (Franson and Peppas, 1983; Alfrey et al. 1966):
Mt
= Ktn (2-4)
M

Where, t is time, k is a constant and n is the time exponent. The time exponent, n,
varies from 0.5 for pure Fickian control to 1 for pure relaxation control. Table 2.2
and Figure 2.4 show that transport kinetics are controlled by diffusion in these
hydrogel systems, since n is close to 0.5(Wang and Wu, 2005).
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Figure 2.3 The swelling degree as a function of time for the different DHPMA
fraction hydrogels

Figure 2.4 log

Mt
versus logTime for the different DHPMA fraction hydrogels
M
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Table 2.2 Dynamic Swelling Parameters
Sample

n

Mt
M

DHPMA0

0.57

0.072-0.569 0.993

0.5

DHPMA20

0.52

0.094-0.557 0.994

1.6

DHPMA40

0.47

0.111-0.554 0.996

2.0

DHPMA60

0.45

0.135-0.532 0.993

2.4

DHPMA80

0.41

0.263-0.589 0.991

3.9

DHPMA90

0.32

0.343-0.568 0.994

4.5

R2

D(cm2S-1)*105

All sample shapes are similar and the ratio of thickness (L) to diameter (Di)
is about 1:10.

It is assumed that water diffuses into a planar sheet at a constant rate.

When

Mt
Mt
≤0.5 the relationship between
and time will fit equation 5 (Crank，
M
M

1978).

Mt
4 Dt 0.5
=
(
)
M
L 

(2-5)

The diffusion coefficient (D) values are estimated according to equation (5) and
shown in Table 2.2.
content.

From Table 2.2 it can be seen that (D) increases with DHPMA

All the swelling kinetics data show that when DHPMA content is increased

the swelling ratio and water diffusion rate increased.

Since water acts as the

diffusion medium between body fluid and the glucose sensor the faster the water
transport characteristics of the hydrogel coating the better the detection of the glucose
concentration.
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2.3.4 DSC Results
Table 2.3 shows that the Tgs of different xerogels composition do vary with
DHPMA content.
2003).

This trend was noted this effect in an earlier study (Gates et al.

The dihydroxypropyl side chain in DHPMA imparts greater free volume,

which can facilitate the mobility and decrease the Tg.

However, this effect is offset

by the extra hydroxyl group which forms hydrogen bonds in the network structures
and restricts mobility

Table 2.3 Tgs of different composition gels
DHPMA%

Tg(℃)(H)

(1) 0

118

(2) 20

119

(3) 40

120

(4) 60

117

(5) 80

117

(6) 90

120

It is well known that the biocompatibility of hydrogels not only depends on the
equilibrium water content but also on the state of water in the hydrogels (Kim et
al.,1980;Mirejovsky et al. 1991;GOxa et al. 2006;Jhon and Andrade, 2004).

Some

techniques employed to study water structure in hydrogels are NMR (Chowdhury et al.
2004; Capitani et al. 2001), dilatometry and electrical conductivity (Lee et al. 1975;
Choi et al. 1977), dielectric relaxation spectroscopy (Kyritsis et al. 1995),
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dynamic-mechanical spectroscopy (Lustig et al. 1991) and differential scanning
calorimetry (Murphy et al. 1988; Pedley and Tighe, 1979).
water in the hydrogels depends on the techniques used.

The classification of

According to the most

common method, DSC, water in the hydrogel is classified as freezing free water,
freezing bound water and non-freezing water.
hydrogen bonding with polymer molecules.

Free water does not take part in

It has a similar transition temperature,

enthalpy and DSC curves as pure water (Nakamura et al. 1983).

Freezing bound

water interacts weakly with polymer molecules and has a phase transition temperature
lower than 273K.

Non-freezing bound water is complexed with the polymer chain

through hydrogen bounds and has no detectable phase transition over the temperature
range from 200K to 273K (Higuchi et al. 1984).

Since the freezing water effects

transport and biocompatibility of the hydrogels (Mirejovsky et al. 1991; Goda et al.
2006). it is important to detect water structure inside hydrogel for optimization of
material properties in biomedical applications.
Table 2.4 Water structures of different composition hydrogels
Sample

EWC% Wf%

Wnf%

Wf/Wnf

Wf/EWC%

D0

48.8

21.6

27.2

0.79

44.3

D20

52.0

30.0

22.0

1.36

57.7

D40

60.1

39.9

20.2

1.98

66.4

D60

65.5

50.7

14.8

3.43

77.4

D80

69.4

56.2

13.2

4.26

81.0

D90

69.9

41.2

28.7

1.44

41.1
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In this work the water structure in equilibrium-swollen hydrogel was studied
by DSC.

Since the peak shape and the maximum peak temperature of heating and

cooling process are dependent on the heating rate (Higuchi and Iijima,1985; Chan et
al. 1992) and different heating and cooling cycles can cause the evaporation of water
from the hydrogel and condensation inside the sample pan(Roorda et al. 1988), only
the results of the first heating runs were used to calculate relative content of freezing
water (Wf%) and the relative content of non-freezing water (Wnf%). The Wf% was
calculated by the melting enthalpy of the hydrogel divided by the melting enthalpy of
pure water.

The observed melting enthalpy is calculated by the area under the

endothermic curve.
et al. 1994 ).

The melting enthalpy of bulk water is taken as 333.3J/g (Ahmad

Wf% and Wnf% are calculated by the following equation:

Wf%=Wfree%+Wf-bond%=

H
100
H w

(2-6)

Wnf%=EWC-Wf%
H w  333.3 J/g
H is the observed melting enthalpy.

H w is the melting enthalpy of bulk water.

The relative content of non-freezing water is obtained by the difference between the
equilibrium water content, EWC, and the relative content of freezing water. The EWC,
Wf% and Wnf% are listed in Table 2.4. Figure2.5 shows the DSC curves obtained
during heating run from -100 ℃ to 20℃.
From Table 2.4 we can see that when the DHPMA content was increased from
0 to 80% the content of freezing water increased and non-freezing water decreased.
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The ratio of freezing water to non-freezing water reached a peak at D80.

The

freezing water increase may be due to greater free volume because of the
dihydroxypropyl side chain while the non-freezing water decrease may be due to
more hydrogen bonds formed between the side chains, which results in less hydrogen
bond formed between water and hydroxyl groups.

According to reference (Liu et al.

2000), hydrogel porosity increased with NaCl concentration in the swelling medium.
This leads to an increase in freezing water content and a decrease in non-freezing
water content and was thought to stem from the increase in porosity, as seen in SEM
pictures, and DHPMA content. However, hydrogels without HEMA showed a
decrease in freezing water and increase in non-freezing water. From the results it can
be seen that 80% DHPMA shows the highest freezing water content.

Since the

content of freezing water determines the transport properties of the hydrogel
(Mirejovsky et al. 1991), it can be expected that 80% DHPMA is the best for transport
of water, glucose and oxygen to the biosensor according to reference(Goda et al. 2006)
higher freezing water content also results in less protein deposition on the polymer
surface.

Future studies will characterize the effect of swelling and water structure on

mechanical relaxations.

Previous publications documented the fact that hydrophilic

groups on the polymer backbone influence secondary relaxations and swelling
responses(Gates et al. 2003).

44

Figure 2.5 DSC heating curves of hydrogels with different DHPMA content,
performed at the heating rate of 5.0℃min-1
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2.3.5 Sensor Performance of Hydrogel-Coated Glucose Sensors
Hydrogels of various compositions were used for coating glucose sensors and
the characteristics of the corresponding sensors were examined in vitro.

Table 5

gives the measured results of sensitivity (S, nA/mM) and response time (T90%, min) at
Day 7 and Day 28.

For different compositions of hydrogels a higher percentage of

DHPMA resulted in the higher sensitivity and shorter response time in accordance
with the results of SEM morphology, swelling behavior and water structure
observations.
Among five hydrogels, D0 showed the best long-term stability but its response
was too slow. D20 to D60 failed to gave a stable sensor response at day 28.
Comparatively, the sensor with a D80 coating showed the best performance. At day
28, the sensor response curve with stepwise glucose increases was still good (Figure
2.6) despite a 40% loss of the sensitivity at day 28.

Table 2.5 Response sensitivities (S) and times (T90%) of various hydrogel (HG)-based
glucose sensors (mean  SD)
Pt-Ir/GOx/HG (n=4)

D0

D20

D40

D60

D80

S (nA/mM)

6.1±2.6

6.3±2.2

10.5±1.7

16.2±0.8

18.4±2.1

T90% (min)

12.7±2.2

10.5±2.0

8.6±1.2

6.9±1.3

4.6±1.0

S (nA/mM)

3.9±0.4

T90% (min)

3.5±1.5

Day 7

Day 28

10.9±2.1
Low response
4.3±1.2
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Figure 2.6 Representative response curves of a Pt-Ir/GOx/HG-D80 glucose sensor at
day 7 and 28, respectively.

47

Table 2.6 Response characteristics of various hydrogel-EPU-based glucose sensors*
(mean  SD)
Pt-Ir/GOx/EPU/HG
Control
D0
D20
D40
D60
D80
(n=4)
S (nA/mM)

3.3±1.1

0.6±0.4

0.6±0.4

1.2±0.8

3.0±1.4

3.2±0.8

T90% (min)

2.9±1.0

27.0±3.4 24.3±2.7 18.4±7.4 17.4±2.2 9.1±1.4

Day 7
*S: response sensitivity of sensor; T90% (min): the time to reach 90% of the maximum
response when glucose varies from 5 mM to 15 mM;

Figure 2.7 Calibration plots from a Pt-Ir/GOx/HG-D80 sensor and a
Pt-Ir/GOx/HG-D80 sensor. Sampling time was between 4 to 5 min after each stepwise
addition of a concentrated glucose solution.
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Figure 2.7 shows the calibration lines of a Pt-Ir/GOx/HG-D80 sensor and a
Pt-Ir/GOx/HG-D80 sensor.
range of 1 to 15 mM.

The linear range of Pt-Ir/GOx/HG sensors was in the

It was thought that the poor linearity at high concentration

could be significantly improved by adding an epoxy-polyurethane membrane in
between the enzyme layer and the hydrogel coating. Such a sensor, i.e.
Pt-Ir/GOx/EPU/HG, extended the linear range to 40 mM (see Figure6).

Table 2.6

summarized the sensitivity and response time of various Pt-Ir/GOx/EPU/HG sensors.
Since the permeability of the epoxy-polyurethane membrane is much lower than that
of the hydrogel coating layer, the epoxy-polyurethane membrane played the major
role in limiting diffusion.

Therefore, when the hydrogel was more permeable, the

sensitivity was closer to that of the control sensors (i.e. Pt-Ir/GOx/EPU).

However,

the additional hydrogel layer caused a significant response delay, especially for D0,
D20, D40 and D60. D80 was determined to meet the design requirement of
implantable glucose sensors.
2.3.6 In vivo Biocompatibility
PU coated Silastic tube ( = ~ 4 mm, length = ~ 50 mm), 80% DHPMA
hydrogel bar ( = ~ 4 mm, length = ~ 50 mm), PU coated glucose sensor and 80%
DHPMA hydrogel coated glucose sensor were implanted subcutaneously in rats for 28
days.

Figure2.8 shows the histology results of the PU coated Silastic tube (A),

hydrogel bar (B), PU coated glucose sensor (C) and hydrogel coated glucose sensor
(D). It can be seen that about 200 µm and more than 500µm in thickness fibrous
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capsule formed around the silastic tubing and PU coated glucose sensor with obvious
inflammation of the cells.

While only 30~ 60 µm in thickness, the fibrous capsule

formed at the hydrogel bar and hydrogel coated sensor, respectively.

80% DHPMA

hydrogel can reduce the fibrosis and inflammation and it should make the lifetime of
glucose sensor longer.

A sensor with a hydrogel coating would not only have all

advantages of an epoxy-polyurethane glucose sensor (e.g. long-term stable, wide
response range) but also minimize the tissue reactions occurring around the implanted
sensor.

This study was limited to 28 days.

There is no reason to expect that the

biocompatibility of this material would change after this period.

As previously

stated in the introduction, the main innovation of this hydrogel compared to similar
materials is the increase in mechanical strength which makes it suitable to coat
biosensors for long term implantation.
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100um
µm
A

B

C

D

Figure 2.8. Histology slides: (A) epoxy-polyurethane-coated silastic tubing ( = ~ 4
mm, length = ~ 50 mm), (B) one hydrogel bar ( = ~ 4 mm, length = ~ 50 mm), (C)
one PU coated sensor (D) one hydrogel coated sensor (rat 4, left) implanted
subcutaneously in rats for 28 days.
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2.4 Conclusion
In this study different hydrogels with various DHPMA content were
successfully synthesized and coated on to glucose sensors by UV polymerization. The
higher freezable water content, swelling rate and uniform porosity that result from
high DHPMA content increase the sensitivity and shorten the response time of the
glucose sensors. The linear range of a glucose sensor only coated with hydrogel is
short. However, it can be improved by coating the epoxy-PU with a layer of hydrogel
because PU can control the diffusion of glucose molecules. Since the hydrogel
minimizes the fibrosis and inflammation, it shows promise for use in implantable
glucose sensors.
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CHAPTER 3
USE OF HYDROGEL COATING TO IMPROVE THE PERFORMANCE OF
IMPLANTED GLUCOSE SENSORS
Foreword:8 D80 coated Pt/GOx/epoxy-polyurethane glucose sensors were implanted
into 4 rats (2 sensors/rat).

The original attempt of in vivo implanted glucose sensors

was not successful, because only 25% of the sensors were working at 4 weeks.

In

order to further improve the efficiency of implanted glucose sensors, another series of
novel hydrogels were developed based on copolymer of HEMA and DHPMA.
3.1. Introduction
The material–tissue interaction during sensor implantation, i.e. so-called
biofouling which may include protein/platelet deposition, or the attachment of
inflammatory response-related cells, is one of the major causes in unpredictable and
unexplainable behaviors of implanted glucose biosensors.

The performance of

implanted biosensors can greatly benefit from the use of more biocompatible outer
most coatings such as hydrophilic alginate (Shichiri et al., 1989), phosphorylcholinemodified polyurethane (Yang et al.,2000), 2-methacryloyloxyethyl phosphorylcholine
-co-n-butyl methacrylate (Nishida et al., 1995; Yasuzawa et al., 2000) and hydrogels
(Suri et al., 2003).

Hemocompatible synthetic copolymers containing phosphorylch-

oline significantly improved the performance of the sensors both ex vivo in whole
blood and in vivo.

Unfortunately, these polymers are mechanically weak and can be

easily dislodged in flowing blood or in the subcutaneous tissue and are thereby are not
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useful for long-term application.

Hydrogels are a kind of network polymer

possessing a degree of flexibility very similar to natural tissue due to their significant
water content.

When in physiological solutions, hydrogels can reduce protein

adsorption and the subsequent inflammatory response.

In the medical field,

hydrogels have been extensively used as scaffolds in tissue engineering and sustained
release drug delivery systems (Norton et al., 2005).

The properties of some

hydrogels make them attractive candidates for use in glucose sensors. A glucose
sensitive phenylboronic acid-based hydrogel used pressure stimuli to detect glucose
(Lei et al., 2006).

Similarly, a polyacrylamide hydrogel-coated cantilever sensor

was constructed and responded to swelling which directly correlated with glucose
concentration (Ji et al., 2005).
gels via crosslinking.

Glucose oxidase was immobilized in polyacrylamide

Swelling and viscoelastic properties were used along with

amperometric measurements to evaluate the materials for use in biosensors
(Fernandez and Lopez, 2005).

Phenylboronic acid containing hydrogels were shown

to exhibit red shifts in holograms which quantify glucose concentrations (Kabilan et
al., 2005).

Another group of researchers used photonic properties of boronic acid

based hydrogels to sense glucose(Alexeev et al., 2004). Berner et al. (1998)
determined that the iontophoretic properties of hydrogels can be used to monitor
glucose.

Certain hydrogels can be doped with glucose-reactive fluorescent dyes and

the light that is emitted changes with glucose concentration (Thoniyot et al., 2006).
Hydrogels can potentially be used as the outermost coating of implanted
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glucose sensors to reduce foreign body reaction surrounding the sensor, thereby
improving the in vivo sensor performance. Polyethylene oxide-based hydrogels were
used as diffusion-limiting membranes in glucose sensors and short-term studies were
implemented by subcutaneously implanting hydrogel-coated glucose sensors in
Sprague–Dawley rats (Quinn et al., 1997, 1995). Most hydrogels like pHEMA are too
weak to maintain their membrane structure and function during implantation,
therefore, long-term studies are difficult.
Hydrogels include neutral hydrogels, ionic hydrogels and swollen
interpenetrating polymeric networks. However, neutral hydrogels can better meet the
sensor coating requirements of biocompatibility and structural stability. A neutral
hydrogel, PHEMA and DHPMA (Wichterle and Lim, 1960),was previously
developed for contact lenses. This gel was shown to exhibit an increased resistance to
dehydration (Gates et al., 2003). The copolymer exhibited high equilibrium water
content and good mechanical properties. These copolymers have great potential for
producing more durable coatings for glucose sensors.
In this study, novel HEMA-DHPMA-based hydrogels were developed and
used to improve the biocompatibility of implantable glucose biosensors. The porosity
and water content of the copolymer were improved by the addition of a structural
strengthener, N-vinyl-2-pyrrolidinone (VP; McConville and Pope, 2001). The
compositions of monomer mixtures were optimized and the resulting hydrogels were
characterized. A selected hydrogel was used for coating an implantable glucose sensor
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(Yu et al., 2006). The in vitro and in vivo sensor performance of hydrogel-coated
sensors were examined and discussed.
3.2 Experimental
3.2.1. Chemicals and Materials
Monomers HEMA and DHPMA were donated by Benz R & D (Sarasota, FL).
Other chemicals including VP, EGDMA and Benacure 1173 were obtained from
Sigma–Aldrich (St. Louis, MO).

VP was purified by vacuum distillation prior to

polymerization according to reference (Jansen et al. 2005).

0.020 inch Silastic

tubing (i.d.×o.d. = 0.51mm×0.94 mm) was purchased from Dow Corning (Midland,
MI). Size 3–0 Prolene (polypropylene) were obtained from Ethicon (Somerville,
NJ).

I.V. catheters (14 ga.) with a needle were obtained from Terumo Medical

Corporation (Somerset, NJ).

Sprague–Dawley outbred rats (male, 375–399 g) were

purchased from Harlan (Dublin, VA).

VetBondTM glue came from 3M (St. Paul,

MN).
3.2.2. Photopolymerization of Poly(HEMA-DHPMA-VP-EGDMA) Hydrogels
Pure monomers (all liquid state) were first combined to prepare the following
four formulations (termed VP0, VP15, VP30 and VP45) listed in Table 3.1.

The

mixtures were diluted 1:1 with deionized water, 1% (w/w) Photoinitiator (Benacure
1173) was added, and the solutions mixed at room temperature.
performed as follows.

Polymerization was

After purging each solution with argon for 2 min, each

solution was transferred into a glass mold (L×W×H=55mm×25mm×1 mm).
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The

molds were placed under a 254 nm UV light for 100–110 min in an argon atmosphere
at 25 ◦C to polymerize the hydrogels.

The hydrogels were removed from the molds

and placed into 500 ml of deionized water at 25 ◦C.

The water was changed daily for

one week to remove soluble residues.

Table3.1 Feed composition of synthesized hydrogel
Molar ratio

VP

1HEMA:1DHPMA

EGDMA

VP0

0

99

1

VP15

15

84

1

VP30

30

69

1

VP45

45
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For formation of the hydrogel coating on the glucose sensor tip, 0.4, 0.8 or 1.2
μl of the argon-purged VP30 solution (including additional water and photo-initiator)
was pipetted onto the sensor tip.

The solution was allowed to spread evenly over the

surface of the tip (bare or EPU-coated).

After exposing to UV light under argon (as

above), the sensors were stored in phosphate buffered saline until further use.
3.2.3. Analysis of Hydrogels
The purified hydrogel samples were cut and freeze-dried for 24 h, and then
stored in dessicator at room temperature. The inner morphology of cutting section
was examined using an S-800 Hitachi Scanning Electron Microscopy System (Hitachi
High Technologies, Pleasanton, CA).
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The glass transition temperature (Tg) was measured using a model 2920
differential scanning calorimeter (DSC, TA Instruments, New Castle, DE) under a
pressurized nitrogen atmosphere to avoid sample degradation.
4–10mg freeze-dried sample was sealed in aluminum pans.
scanned from 30 to 200 ◦C at 5◦C per min.

In this process, a

The samples were

Each sample was tested at least twice.

Fourier transform infrared spectroscopy (FT-IR) was carried out on the
rectangular samples that were dessicated at room temperature after freeze-dried, using
a Nicolet Avatar 320 FT-IR Spectrophotometer (Nicolet, Madison, WI) with a 64 scan
per sample cycle at a resolution of 4 cm−1.
For the determination of equilibrium water fraction (EWF), hydrogel samples
were lyophilized to obtain dry mass (Md). Xerogels were then swollen in a pH 7.4
phosphate buffer solution (PBS, ionic strength =~0.16 M) at 37 ◦C for 2 days. The
swollen hydrogels were pat-dried with filter paper and weighed every 2 h until the
weight reached a constant value (Meq). The water Fraction (EWF) at swelling
equilibrium was calculated by:
EWF(%) = (Meq −Md) × 100/Md

(3-1)

3.2.4. Sensor Preparation
Glucose sensors were based on coil-type design (Yuet al., 2006)(Figure3.1).
Briefly, the coil-type glucose biosensors were prepared by winding the top 10mm of a
40–50mm long platinum wire (Φ0.125mm, including 10% iridium in weight) along a
30-gauge needle to form a coil-like cylinder which was filled with cotton.

The

enzyme layer was formed over the cylinder by coating an aqueous solution of
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10mg/ml GOx, 30–40mg/ml BSA and 0.6% (v/v) glutaraldehyde.

In this study, the

novel membrane configurations were used on Pt/GOx or Pt/GOx/EPU sensors.

The

outermost hydrogel coating was formed by applying a 0.4–1.2μl of 50% hydrogel
solution to the Pt/GOx or Pt/GOx/EPU sensors as described above.

All sensors used

in this study were visually inspected for defects under 40× magnification using a
dissection microscope (Figure3.2) and then stored in PBS.
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Figure 3.1 Schematic diagram of hydrogel-coated sensing element of the glucose
electrode. Figure adapted from Ju (Ju, 2006).
(1) Teflon-covered Pt-Ir wire;
(2) Ag/AgCl reference wire;
(3) Collagen scaffold;
(4) Electrically-insulating sealant;
(5) Epoxy-Pu outer membrane;
(6) Enzyme layer;
(7) Stripped and coiled Pt-Ir wire;
(8) Cotton fiber with GOX gel.
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Ag/AgCl Electrode

1 mm

Sensing Element with
Hydrogel Coating

Figure 3.2 Photo of sensor coated with hydrogel (40× magnification using a dissection
microscope)
3.2.5. In vitro Sensor Evaluation
The in vitro performance of the sensors was examined in glucose/PBS to
determine the response time, sensitivity and linear range of sensors at different days.
The response time represented the required time to reach 90% of the maximum
response when the glucose concentration increased from 5 to 10mM.

The sensitivity

of the Pt/GOx/hydrogel sensors was measured using 5 and 10mM glucose/PBS.
linear range was obtained from a stepwise glucose increase from 2 to 30mM.

The

All

test solutions were prepared using pH 7.4 PBS (ionic strength =~0.16M) and
amperometric measurements were performed at room temperature at 0.7V vs.
Ag/AgCl.
3.2.6. Animals and Surgical Procedures
The sensors were disinfected during polymerization of the hydrogel coating
under a 254 nm UV light.

Sensors used for implantation were pre-conditioned in
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sterile saline for 2 days.

The sensor immobilization method for implantation was

according to paper (Long et al., 2005) and further improved. Briefly, the sensor wires
were covered with a section of 0.02 in. silastic tubing (2 cm in length).

An overhand

knot then was made in the middle of this section to use as a suturing site (i.e. for
anchoring) during implantation and to prevent the sensor moving out of the skin.
For each sensor placement (two/rat), a ~1.5 cm length longitudinal incision was made
1.5 cm laterally to the dorsal midline, 3–4 cm caudally from the neck.

A

subcutaneous pocket was created by using blunt surgical scissors before sensor wire
placement. A 14 ga. I.V. catheter was inserted through the subcutaneous tissue area
to the incision from the low back.
the subcutaneous tissue.
through the incision.

The needle was withdrawn leaving the cannula in

The sensor tip and wires were carefully fed into the cannula

The sensor was secured to the skin by passing a 3–0 Prolene

suture through the knot of the silastic tubing covered sensor wires and the incision
was closed using 3–0 Prolene sutures.

After implantation, a ~4mm length of Silastic

tubing containing a ~8mm length of sensor wires was allowed to protrude from the
skin.
All protocols were approved by the University of South Florida Institutional
Animal Care and Use Committee (IACUC).
3.2.7. In vivo Evaluation Method
During the course of in vivo testing, a continuous flow anesthesia system was
used to deliver 1.5% isofluorane to the rats with 1.0 l/min oxygen.

A maximum of 8

sensors were continuously monitored for 2–3 h by using two Apollo 4000
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potentiostats (4 channels each; World Precision Instruments, Sarasota, FL).
Response currents (nA) were acquired at 1 s intervals every second and dynamic
current (nA) vs. time (s) curves for all sensors were simultaneously displayed.

After

a run-in period of approximately 1 h, a stable signal was obtained from the sensors.
Dextrose (0.5–0.8 ml of a 50% (w/v) solution) was administered intraperitoneally
using a 27 ga. needle.
procedure.

Figure 3.3 shows the in vivo continuous glucose monitoring

Following the injection, a drop of blood was sampled every 6–8 min

from the transected distal rat tail and blood glucose level was determined using a
portable glucometer (FreeStyleTM; TheraSense, Alameda, CA).

The sensor

sensitivity was calculated by dividing the current change by the blood glucose
difference between the initial (before dextrose injection) and the peak status (after
dextrose injection).
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Figure 3.3 In vivo Continuous Glucose Monitoring Procedure. Figure adapted
from Ju’s dissertation
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3.3 Results and Discussion
3.3.1. Characterization of Hydrogels
After polymerization, hydrogels VP0, VP15, VP30 and VP45 were transparent
and colorless in appearance and had a uniform and smooth surface, indicating that
addition of VP did not result in phase separation or deterioration in the uniformity of
the cured hydrogels.

FT-IR spectrometry (shown in Figure3.4) revealed specific

carbonyl adsorption peaks at ∼1735 cm−1 (corresponding to polymerization of
HEMA o rDHPMA) and∼1655 cm−1 (corresponding to polymerization of VP)
(Yaung and Kwei, 1998).

As VP concentration was raised, the VP carbonyl peak

increased. FTIR results indicate that VP was successfully co-polymerized with
HEMA and DHMPA.
The measured glass transition temperature values (Tg) of VP0, VP15, VP30
and VP45 were 111.88, 121.72, 133.86 and 143.75oC, respectively (shown in
Figure3.5).

Due to formation of hydrogen bonds between the carbonyl group in the

PVP network and OH groups on the PHEMA or PDHPMA chains, VP effectively
enhances the interactions between polymer chains and restricts the mobility of chains
(Jin et al., 2006). Consequently, Tg values increased with increasing VP
concentration.
VP improved porosity of the hydrogels. Without VP, the copolymer of HEMA
and DHPMA did not show pores in Figure 3.6 while the hydrogels with VP were
highly porous.

The pore size increased when VP increased in the range of 0–45%.
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According to higher magnification SEM photos (Figure3.7), it can be seen that nets
start to appear inside the gel on the surface of the pores from VP15 and VP30.

There

are more nets insede VP30 than VP15. When it is magnified to 10K times, it can be
seen that some big pieces of structures combined with nets present on the surface of
the pores.

The diameter of net string is about 50nm.

However, there are no nets on

the surface of pores of VP45.
Equilibrium water fraction EWF values for VP0, VP15, VP30 and VP45 were
146%, 149%, 166% and 217% (wt%), respectively.

In consideration of

biocompatibility, the hydrogel with a large EWF and large pores would be preferred.
In order to detect the durability of these novel hydrogels, hydrogel samples (n
= 4/hydrogel) were stored in water at room temperature for 4 weeks.
significant weight loss was observed.
several smaller pieces.

Fortunately, no

However, VP45 spontaneously broke into

From SEM pictures (Figure3.6 and 3.7) nets are present

inside the gel on the surface of the pores of VP15 and VP30.

These nets may

strengthen polymer matrix with high water content. Since there are no nets on the
surface of pores of VP45, VP45 was observed fragility probably due to swelling
stresses as a result of the high water content.

Balancing the properties of water

content, porosity and durability of various hydrogels, VP30 was selected for coating
sensors for more in-depth in vitro/in vivo performance testing.
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Figure 3.4 FTIR of four freeze-dried samples (the thickness of samples are
around 0.5mm, taken by reflected light)
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Figure 3.5 DSC of four freeze-dried samples
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Figure 3.6 A SEM of sample VP0

Figure 3.6 B SEM of sample VP15
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Figure 3.6 C SEM of sample VP30

Figure 3.6 D SEM of sample VP45
Figure 3.6 Scanning electron microscopy images of four freeze-dried hydrogel
samples (magnification: 350×, bar = 50μm).
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Figure 3.7 A SEM of sample VP15(magnification

)

Figure 3.7 B SEM of sample VP30(magnification

)
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Figure 3.7 C SEM of sample VP30(magnification

Figure 3.7 D SEM of sample VP30(magnification

)

)

Figure 3.7 Scanning electron microscopy images of VP15 and VP30
freeze-dried hydrogel samples with different magnification
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3.3.2. In vitro Performance of Pt/GOx/VP30 Sensors
In order to improve the long-term biocompatibility of the sensors in vivo, the
hydrogel coating must be thick enough to be durable.

On the other hand, if the

coating is too thick and/or relatively less porous, the sensor response will be very
slow. The wet coating thickness was estimated by the volume of the coating solution
(Vc).

Volumes of 0.4, 0.8 and 1.2 μl of VP30 solution on the enzyme layer of

Pt/GOx sensors (n = 4).
diffusion-limiting membrane.

In this case, the hydrogel layer served as the
Compared to the control sensors (Pt/GOx), the

hydrogel layer did not improve the sensor response linearity; neither did it
significantly reduce sensitivity except for the thicker coating (Table 3.2).

The

calibration plots from Pt/GOx/VP30 sensors with coating layers formed from 0.4, 0.8
and 1.2μl of VP30 solutions are shown in Figure 3.8.
improve linearity but reduced sensitivity.

The thicker coating did not

After the sensors had been in water for 28

days, all coatings were still firmly attached to the sensors but the sensitivity decreased
~50%.
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Table 3.2 Influences of Coating Thickness on Sensor Response

Sensor
(n=4)
Pt/GOx
Pt/GOx/VP30
Pt/GOx/EPU
Pt/GOx/EPU/VP30

VP30
Coating
Volume
(µL)
0.0
0.4
0.8
1.2
0.0
0.4
0.8
1.2

S
(nA/mM)

T90%
(min.)

48.2±6.3
47.6±2.8
45.4±1.5
34.7±1.8
3.0±2.1
3.0±1.6
2.9±2.2
2.7±0.6

0.22±0.07
1.1±0.1
1.4±0.2
1.9±0.3
1.4±1.1
3.4±0.9
6.4±3.0
8.1±2.2

Figure 3.8 Calibration plots for Pt/GOx and Pt/GOx/VP30 glucose sensors.
Data are the means of measurements from 4 sensors at day 3. Error bars are ±standard
error.
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3.3.3 In vitro Performance of Pt/GOx/EPU/VP30 Sensors
Due to the poor linearity, Pt/GOx/VP30 sensors might not be able to meet the
basic requirement of in vivo measurements for accuracy and precision.

Though

non-linear calibration can be performed in an effort to improve measurement
reliability, a better solution is to add an additional diffusion-limiting membrane in
between the hydrogel layer and the enzyme layer, for example, a low permeability
epoxy-polyurethane membrane (Yu et al., 2006).

Such sensors with hydrogel

coating, i.e. Pt/GOx/EPU/VP30, were prepared using similar methods as those used
for preparing Pt/GOx/VP30 sensors and tested in glucose/PBS.

It was found that

hydrogels could firmly attach to the epoxy-polyurethane membrane.

The sensitivity

was decreased to about 10% of the sensitivity of Pt/GOx/VP30 sensors, which did not
change with an increase in hydrogel coating (Table 3.2).

This was because the

epoxy-polyurethane was much less permeable than the hydrogel and played the
decisive diffusion-limiting role.

The linearity of the sensor’s response was

significantly improved by the epoxy-polyurethane membrane and was at least in the
range of 2–30mM.

The sensor response was dramatically delayed when the

hydrogel coating was thicker (the response time is proportional to the square root of
membrane thickness (Baronas et al., 2003).

For 0.4, 0.8 and 1.2 μl of hydrogel

coating, the response time was 3.4±0.9, 6.4±3.0 and 8.1±2.2 min, respectively.

Thus,

further experiments were carried out using the sensor with 0.4 μl of VP30 coating.
The Pt/GOx/EPU/VP30 (0.4μl) sensors did not show a decline in either sensitivity or
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linearity over 28 days (Figure 3.9). The coating was still visible and firmly attached
to the sensor after 28 days.
3.3.4. In vivo Performance of Pt/GOX/EPU/VP30 Sensors
Eight Pt/GOx/EPU/VP30 (0.4 μl) sensors were subcutaneously implanted in
four rats (two sensors/rat) and the in vivo sensitivity of each sensor was tested at days
7, 14, 21 and 28.

The testing results are summarized in Table 3.3.

All sensors kept

functioning in the first 3 weeks and produced an in vivo response sensitivity of ~4
nA/mM. At day 28 after implantation, 3 of 8 implanted sensors still performed.

It

has been reported that 68 Pt/GOX/EPU sensors were tested in vivo and the sensor
survival at day 21 was 13.5% (Long et al., 2005).

This suggests that the addition of

hydrogel coating apparently improves the long-term performance of the implanted
glucose sensors.
The improvement might be attributable to the excellent biocompatibility of the
hydrogel coating.

Representative histological sections, prepared from tissue

surrounding a Pt/GOx/EPU/VP30 sensor and a Pt/GOx/EPU sensor at day 28 after
implantation, are shown in Figure 3.10. Only a few inflammatory cells were observed
in the tissue surrounding hydrogel-coated sensors (Figure 3.10B). Without hydrogel
coating, many inflammatory cells appeared (Figure 3.10A).

The thickness of the

fibrous tissue around the Pt/GOx/EPU/VP30 sensor was 50–100μm, much less than
the thickness of 100–500μm which was routinely observed in tissue surrounding
Pt/GOx/EPU sensors (Long et al., 2005).

The reason for the functional failure of the

other five sensors at day 28 in this study is unknown. Histological results did not
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show any apparent differences between the tissue surrounding the surviving sensors
and the tissue surrounding the failed sensors.

Table 3.3 In vivo sensor sensitivity of Pt/GOx/EPU/VP30 sensors (n=8)
Rat No. 1

2

3

4

Average ±1

Sensor

left

right

left

right

left

right

left

right

Standard Error

Day 7

12.0

5.5

2.6

2.1

4.6

1.2

2.6

1.4

4.0 ±1.3

Day 14

4.4

7.3

1.5

5.8

3.4

1.9

4.2

2.1

3.8 ±0.7

Day 21

6.6

4.2

1.5

5.6

5.3

2.1

2.0

5.4

4.1 ±0.7

Day 28

0

0

0

0.9

0

0

4.2

2.2

N/A
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Figure 3.9 Calibration plots for Pt/GOx/EPU/VP30 (0.4ul) sensors at day 3, 7, 16 and
28. Data are the means of measurements from 4 sensors. Error bars are ±standard
error.
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A

Inflammatory
Cells

100 μm

Hydrogel
Debris

B

100 μm

Figure 3.10 Hematoxylin and eosin-stained sections of tissue surrounding glucose
sensors implanted subcutaneously in rats for 28 days. The photo (A) shows the
capsular tissue formed around a Pt/GOx/EPU sensor. The photo (B) shows
thecapsular tissue formed around a Pt/GOx/EPU/VP30 (0.4μl) sensor.
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3.4. Conclusion
This study has provided a feasible approach to design and select the properties
of the copolymer for coating implantable biosensors. For the first time, animal
experiments were used to demonstrate that a hydrogel coating was effective in
minimizing tissue reactions surrounding implanted minimally invasive needle-type
glucose biosensors. With a hydrogel outermost coating and an appropriate
diffusion-limiting layer, significant improvements of the in vivo performance of
implanted glucose sensors can be anticipated.
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CHAPTER 4
EFFECT OF NOVLE HYDROGEL COMPOSITION ON TARGETED
DEXAMETHASONE-21 PHOSPHATE DISODIUM SALT DELIVERY

4.1. Introduction
When implants such as biosensors, pacemakers and bioartificial organs are
implanted in the body, acute inflammation can occur within seconds or may be
delayed for days.
usually follows.

Without suppressive agents, chronic inflammation and fibrosis
The implants will lose normal functions with these tissue reactions

(Hickey et al. 2002).

According to recent reports (Norton et al. 2006;Patil et al.

2004;Yoon et al.2003;Klueh et al. 2007), the local release of DX can suppress the
acute inflammation around the biosensors and may improve biocompatibility and
prolong sensor lifetime.

The dexamethasone concentration around the implant

depends on the drug release characterization from the matrix and must be high enough
to prevent inflammation (Moussy et al.2006).

The drug release from equilibrium

swollen hydrogel can be affected by both drug and materials used (Karlgard et al.
2003).

Norton et al (Norton et al. 2005; Gallardo et al. 2001) used HEMA-VP-PEG

hydrogel as a matrix for DX release, but there is no report about the effect of hydrogel
compositions on DX releasing.

It has been reported that polymer structure and

composition greatly influenced drug release, so it was a matter of importance to focus
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on the effect of hydrogel composition on the targeted delivery of DX-21.
In this phase of the research, a serious of porous poly(HEMA-DHPMA-VP)
matrixes are prepared in the membrane form according to previous two chapters.
The water soluble DX-21 was loaded into the hydrogel followed by the study to
determine drug load and release.

The simple HPLC method was developed to detect

both DX and DX-21 using the same mobile phase.
4.2 Experimental
4.2.1 Chemicals
2-Hydroxyethyl methacrylate (HEMA) and 2, 3-dihydroxypropyl methacrylate
(DHPMA) were donated by Benz R & D (Sarasota, FL，USA)and used as received
without further purification.

N-Vinyl-2-Pyrrolidinone (VP) (99.9+%) was purchased

from Sigma-Aldrich Co.( St. Louis, MO, USA) and purified by vacuum distillation to
obtain a colorless liquid (Janson et al. 2005). Ethylene glycol dimethacrylate
(EGDMA),

Dexamethasone-21 phosphate disodium salt (98%, powder) and

monobasic potassium phosphate ACS grade from Sigma –Aldrich Co. (St. Louis, MO,
USA) were used as received.

Methanol HPLC grade from Fisher Scientific (Fair

Lawn, NJ, USA) and Benacure 1173 from Mayzon Corporation (Rochester, NY,
USA). Phosphate buffered saline (PBS) 10X solution from Fisher Scientific (Fair
Lawn, NJ, USA)was diluted to 1X with pH 7.4±0.1.
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4.2.2 Drug loading by Equilibrium Partitioning
The homemade swollen hydrogels were cut by the core bore (diameter,
5.73mm) and freeze-dried for one day to obtain xerogel pellets which are kept in the
descicator until used.
Xerogel pellets were weighed, wrapped in the net and placed in individual
vials with 3mL of 25mg/mL dexamethasone-21 phosphate disodium (DX-21)
solutions.

The pellets were immersed in the solutions which were stirred and

incubated in 37℃ oil bath for 24 hours.
4.2.3 In vitro Release Study
Drug-loaded hydrogels were removed from drug solution.

The excess

solution on the surface of the hydrogels was removed by using Kimwipes.
Drug loaded hydrogel were wrapped again in the net and placed into 3mL
fresh PBS solution which was stirred and incubated in 37℃ oil bath.

PBS at

pH7.4±0.1 at 37℃ resembles the environment of the drug inside the human body.
At different time intervals, hydrogels were removed and placed in fresh PBS solutions
to keep the sink condition.

The drug solutions were kept in the refrigerator prior to

detect the DX-21 and DX concentration.

Three in vitro release studies were

performed under the same conditions for each hydrogel sample. The means were
calculated and graphed for each different time interval.
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4.2.4 HPLC Analysis of DX-21 and DX Release
4.2.4.1 Preparation of Standard Solution
An accurately weighed quantity of DX-21 was dissolved in different mobile
phase (Table 4.1)to obtain a known concentration of about 535.20ug/mL. Stock
solution was diluted to obtain 5.35, 10.70, 21.41, 42.82, 53.52, 64.22, 85.63 and
107.04 ug/mL solution.
A known amount of DX-21 was weighted and dissolved with mobile phase to
obtain a known concentration of 98.80ug/mL.

The stock solution was diluted to

obtain 79.00, 59.30, 49.40, 39.50, 19.75, 9.88 and 4.94 ug/mL solution.
4.2.4.2 HPLC System
The concentration of the solution was monitored by HPLC with Shimadzu
system controller, UV-vis detector, and liquid chromatograph.

The column is

Shimadzu premier C18 5um 150*4.6mm. The wavelength was 241nm, and the flow
rate was 1 mL/min.
4.2.4.3 Selection of the Mobile Phase
Different mobile phases were prepared according to table 4.1 and degassed by
ultrasonic. The mobile phase ran about half hour until the base line was stable.
First, 39.5 ug/ml DX and 42.82 ug/ ml DX-21 were separately injected.

Second, the

mixture of 10ml 79.00 ug/ml DX and 10ml 85.63 ug/ ml DX-21 was injected.
De-ionized water is used to clean the tube and column for two hours. After that a
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new mobile phase ran about one hour before the drug solution was injected. The
same procedure was repeated to test different mobile phase.
4.2.4.4 Calibration Curve and Sample Assay
The peak area under the curve was plotted to the standard concentration to
obtain the calibration line.

The formula derived from the line was used to calculate

the drug concentration of the samples.
The samples were injected to the 20uL auto valve. Every sample was injected
at lease twice. If the error was beyond 5%, a third injection was done. The
concentration of the solution was taken as the average value.

The mass of the drug

equalled the average of the triple experiments.
4.3. Results and Discussion
4.3.1The Selection of the Mobile Phase
Dexamethasone -21 phosphate disodium (DX-21)(Figure4.1), prodrug of
dexamethasone, can convert to dexamethasone(DX) (Figure4.2)in biological fluids in
vitro(Blackford et al. 2000).
convert to DX too.

During the release experiment, some DX-21 molecules

Different mobile phases have developed to determine DX-21 and

DX separately (Blackford et al. 2000).

It was too costly and time consuming to use

different mobile phase to detect DX and DX-21 separately; therefore, a single mobile
phase that could be used to detect both was necessary. Table 4.1 shows different
mobile phases are used to separate DX-21 and DX.
According to Tabel 4.1, it is seen that DX-21 is eluted earlier than DX because
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DX-21 is more polar than DX since reverse HPLC was used. When the polarity of
mobile phase decreases, retention times of DX-21 and DX are extended.

When the

ratio of methanol to water arrives at 6:4, DX-21 and DX can be separated.

They can

further separated by mobile phase of methanol: water (5:5). However, retentions
time of DX-21 (2.850 and 3.175) are so short that they are close to the dead time of
the column which is about 2min. When the 0.01M KH2PO4 is added to the mixture,
it makes the retention time of DX-21 longer, while the retention time of DX shorter.
Both of the two mobile phases of methanol:water (6:4) and methanol :water(5:5) can
separate DX-21 and DX too.

Furthermore, the peak of DX-21 can be separated from

dead volume of column.

In order to save time, methanol: water (6:4) with 0.01M

KH2PO4 was preferred.

Figure 4.3 shows HPLC profiles of DX-21 and DX with

mobile phase of methanol:water(5:4, 0.01KH2PO4).

Figure 4.1 structure of Dexamethasone 21-phosphate disodium
salt(DX-21)
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Figure 4.2 Structure of dexamethasone

Table 4.1Mobile phase and Retention time
Retention time
Retention time DX
Mobile phase

DX-21
(min)
(min)

100% methanol

2.075

2.117

Methanol :water=7:3

2.658

3.392

Methanol:water=6:4

2.850

6.725

Methanol: water=5:5

3.175

17.342

Methanol:water=5:5(0.01MKH2PO4)

9.942

16.625

Methanol:water=6:4(0.01MKH2PO4)

4.533

6.558
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Figure 4.3 A

Figure 4.3 B

Figure 4.3 C
Figure 4.3 HPLC profiles with mobile phase Methanol:water=6:4(0.01MKH2PO4):
A.DX-21 B. DX C. DX-21 and DX

Table 4.2 Regression parameters for DX and DX-21
formula

R2

n*

DX-21

3E-5x-1.0425

0.9986

21

DX

1E-5x+0.0707

0.9880

21

n* is the number of experiments: seven samples with three times injection each
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Table 4.2 shows the calibration formulas of the DX-21 and DX,
y=3E-5x-1.0425 and y=1E-5x+0.0707 separately, x is the area under the peak, and y
is drug concentration.

The concentrations of DX-21 and DX are calculated by these

two formulas with the area under the peak.
4.3.2 Drug Loading by Equilibrium Partitioning
DX has often been loaded to hydrogels by putting certain amount of DX in the
monomer solution before polymerization because it is not water soluble (Norton et al.
2005). With this kind of method, the obtained hydrogel can’t be purified after
polymerization due to the loss of drug, and the drug may not stable during the
polymerization.

For the current research effort, DX-21, pro-drug of DX-21, was

chosen for its high water solubility.

It has been reported that highly hydrophilic

hydrogels are useful for the release of water soluble drugs that can be immobilized in
the hydrophilic matrix by physical entanglement (Barbu et al. 2005).

Furthermore,

hydrogels can be loaded with water soluble drugs by partitioning it into the polymer
matrix when the purified xerogel swells in the drug water solution after
polymerization (Kim et al.1992).
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Table 4.3 drug loading percents & EWCs of hydrogels with DX-21
sample

Load(%)a*

EWC%

D0

4.75

52.8

D20

8.95

64.4

D40

11.16

71.8

D80

15.73

77.2

VP0

13.3

73.5

VP15

13.4

73.7

VP30

21.2

74.6

VP45

20.1b*

75.6

a*Load(%)=Mass of total DX-21/Mass of Xerogel
b*VP45 tears during releasing experiment
The DX-21 loading percent is calculated by mass of cumulated release amount
of DX-21 and DX divided by mass of xerogel.

When xerogel is immersed in the

drug solution, drug enters to the polymer due to three types of driving forces: a drug
concentration gradient, a polymer stress gradient and the osmotic forces (Brazel and
Peppas, 1999).

Therefore, a higher degree of swelling is caused by the polymer

stress gradient and osmotic forces which allow greater amounts of drug imbibed in the
polymer matrix.

From above table 4.3, it can be seen that DX-21 loading percent

increased with the swelling degree of hydrogels in each series.
According to Karlgard et al.’ s work, their contact lenses only up-took about
67±13ug DX-21 and the release could not be evaluated due to the low concentration
of drug released.

The lowest maximum uptakes observed for DX-21 can be
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explained by the high aqueous solubility of DX-21 which would remain preferentially
in solution rather than within the lens material (Karlgard et al.2003).

According to

results of table 4.3, the drug uptakes of different formulations of hydrogels are much
more than Kalgard et al’s research.

The high aqueous solubility of DX-21 does not

appear to be the reason for the lowest uptakes of DX-21.
with Peppas’s results regarding hydrophilic drugs.

This result is consistent

It is reported that the amount of

drug loaded into xerogel is a function of the partition coefficient between the drug in
solution and the gel itself, hydrophilic drugs which are more soluble in the loading
solutions are loaded to higher concentration into polymer samples (Brazel and Peppas,
1999).
4.3.3 Drug Release
After surgical implantation of the glucose sensors, the acute inflammatory
response normally takes place within seconds.
inflammatory cells adsorb to the sensor surface.

During the initial stage, proteins and
Phagocytic cells (e.g., neutrophils,

monocytes, and macropages) then surround the device within minutes to hours in an
effort to destroy it. Such membrane biofouling is detrimental to sensor function
resulting in restriction of analyte diffusion to the sensor and/or degradation of the
sensor membrane (Shin and Schoenfisch, 2006).

If the acute inflammation cannot be

suppressed, the chronic inflammation will be sustained from weeks to lifetime. This
may result in the forming of fibrosis around the implanted glucose sensors and enable
the implanted glucose sensors lose the valid function (Shin and Schoenfisch, 2006).
In order to prevent the acute inflammation and prolong the lifetime of the implanted
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glucose sensors, both penetration rate and concentration of anti-inflammatory drug
around the tissue should be high enough to suppress the inflammation (Moussy et al.
2006). According to the results from figure 4.4 and 4.5, all hydrogels showed a high
initial release, followed by slow, long term release during the next hours to days.
This function is believed to be good for the implanted glucose sensors to suppress the
acute inflammation and chronic inflammation.
Drug release kinetics from hydrogels can be expressed by the following
equation (4-1):

Mt
=ktn
M

(4-1)

Where Mt is the amount of release at time t, M  is the initial drug loading,
Mt
is the fraction of drug released, t is the release time, n, drug release exponent, and
M

k is a constant incorporating the structural and geometrical characteristics of the
release device.

It has been reported that n=1 is Case II release kinetics and n=0.5

corresponds to the Fickian release kinetics (Ritger and Peppas, 1987).

The values of

n were derived from the linear regression slopes of the release profiles (Mt/ M  ) <0.6
using above equation shown in Figure 4.5.

It shows that n is about 0.5 which

indicates the release mechanism is Fickian diffusion.
Average DX-21 release rates from hydrogels can be expressed by the
diffusion coefficient.

All sample shapes are similar and the ratio of thickness (L) to

diameter (Di) is about 1:6.5.
constant rate. When

It is assumed that water diffuses into a planar sheet at a

Mt
Mt
≤0.5 the relationship between
and time will fit
M
M

93

equation 5 (Kim et al. 1980).
Mt
4 Dt 0.5
=
(
)
M
L 

(4-2)

The diffusion coefficient (D) values were estimated according to equation (5)
and shown in Figure 4.6 and Table 4.4.

From Table 4.4 it can be seen that average

DX-21 release rates from DHPMA series hydrogels increases with DHPMA content
due to higher equilibrium water content, initial DX-21 loaded percent and more pores.
The higher initial drug loaded percent causes higher concentration gradient between
hydrogel and fresh PBS solution which acts as the driving force for the drug diffusion.
The pores of polymers work as a tunnel for drug transport.

Since water is the

vehicle to transport the drug out of polymer, higher water content will facilitate drug
diffusion.

Factors influencing drug releasing behavior is related to the drug uptaking

behavior: concentration gradient, equilibrium water content and pores which are
dictated by polymer composition.
For VP series hydrogels, average release rates of VP15 and VP30 are lower
than VP0 and VP45.
surface of pores.

According to SEM figures 3.4, there are nets that appear on the

These nets may work to block DX-21 transport out of the hydrogel.

There are more nets on the surface of VP30 pores than in VP15.

The average release

rate of VP30 is also slower than VP15. This confirms that the polymer
inner-morphology is another factor that greatly influences drug diffusion.
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Figure 4.4 A initial burst release

Figure 4.4 B low level long term release
Figure 4.4 DX-21Cumulative release profiles from DHPMA hydrogels
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Figure 4.5 A initial burst release

Figure 4.5 B low level long term release
Figure 4.5 DX-21Cumulative release profiles from VP hydrogels
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A. DHPMA series

B. VP series
Figure 4.6 Drug release kinetics log(Mt/Meq) versus log Time
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Table 4.4 DX-21 release exponents and coefficients

n

R2

D(ҳ108cm2S-1)

D0

0.4394

0.9958

2.60±0.08

D20

0.4964

0.9970

13.80±0.13

D40

0.4177

0.9987

21.76±1.03

D80

0.4780

0.9969

62.36±4.04

VP0

0.5649

0.9980

38.37±1.12

VP15

0.5022

0.9995

33.70±2.54

VP30

0.4422

0.9999

27.67±0.23

VP45

0.4193

0.9999

52.30±2.72
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4.4. Conclusion
The mobile phase methanol:water=6:4(0.01MKH2PO4) could separate DX and
DX-21 at the same run so it is available to detect both DX and DX-21 by a simple
HPLC method.
DX-21 was successfully loaded into a series of hydrogels by equilibrium
partitioning.

The drug loaded percents show that D80 could uptake the maximum

DX-21 due to high equilibrium water content and more pores.

The drug release

kinetics shows that DX-21 releasing mechanism from novel hydrogels is Fickian
diffusion. The factors influence drug releasing behavior is relative to drug uptaking
behavior: concentration gradient, inner-morphology and water content which are
decided by polymer composition.
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CHAPTER 5
WATER STRUCTURE IN HYDROGELS
5.1. Introduction
The study of water structure in the hydrogels can assist in determining the
biocompatibility of the hydrogel and affect the transportation of the molecules
between the matrix and intermediate.

An investigation of water structure in a

polymer yields valuable information on the sorption, diffusion and permeation
properties of molecular species in hydrophilic polymers.(Ping et al. 2001)

Most

research on water structure in hydrogels has focused on the water in hydrogels using
deionized water or PBS solution as media (Goda et al.2006; Liu and Huglin, 2003;
Ping et al. 2001;Ahmad and Huglin, 1994).

Research conducted by Stevenson and

Gates compared water structures in hydrogels at equilibrium in different media such
as water and PBS (Stevenson and Sefton,1988; Gates and Harmon, 2001). However,
there is no report about water structure in hydrogels which swell to reach equilibrium
when immersed in drug solution.
Water structure in hydrogels can be detected by differential scanning
calorimetry (DSC)(Murphy et al. 1988; Pedley and Tighe, 1979),NMR (Chowdhury et
al. 2004;Capitani et al. 2001), dilatometry, electrical conductivity (Lee et al.
1975;Choi et al. 1977), dielectric relaxation spectroscopy (Kyritsis et al. 1995), and
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dynamic-mechanical spectroscopy (Lustig et al. 1991).

The most common method

is DSC. Using DSC, water in a hydrogel is classified as free water, freezing bound
water and nonfreezing water. Free water does not take part in hydrogen bonding with
polymer molecules. It has a similar transition temperature, enthalpy and DSC curves
as pure water (Nakamura et al. 1983).

Freezing bound water interacts weakly with

polymer molecules and has a phase transition temperature lower than 273K.
Non-freezing bound water is complexed with the polymer chain through hydrogen
bonds and has no detectable phase transition over the temperature range from 200K to
273K (Higuchi et al. 1984).
It was previously discussed that equilibrium water content of the hydrogel is
one important factor affecting drug diffusion.

It is known that freezing water content

is essential for predicting efficient diffusion of salts and macromolecules (Pedley D.G.
and Tighe 1979). Hydrogel coatings loaded with DX-21will be implanted and come in
contact with different body fluids which contain many small water soluble molecules.
When these small molecules diffuse into hydrogels and DX-21 molecules diffuse out
of hydrogels, the water content and structure in hydrogels may change too.
Therefore, it is very important to investigate the water structure in hydrogels at
equilibrium in small molecule media and DX-21 solution. In this chapter,
1HEMA:1DHPMA copolymer and 3 VP-HEMA-DHPMA copolymers were used to
study the water structure. PBS was chosen as the media for small molecules because it
is similar to body fluid. The water structures of these hydrogels were studied by DSC.
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5.2. Experimental
5.2.1. Chemicals
Four different polymers were prepared as described in chapter 3: one
HEMA-DHPMA

copolymer

and

three

VP-HEMA-DHPMA

copolymers.

Dexamethasone-21 phosphate disodium salt (98%, powder) ACS grade was purchased
from Sigma –Aldrich Co. (St. Louis, MO, USA) was used as received. Phosphate
buffered saline (PBS, 11.9mM Phosphate, 137mM Sodium Chloride, 2.7mM
Potassium Chloride) 10X solution from Fisher Scientific (Fair Lawn, NJ, USA) was
diluted to 1X with pH 7.4±0.1.

5.2.2. Instrumentation
All water structure data were obtained by measuring heat flow with a TA
Instruments 2920 differential scanning calorimeter (DSC). DSC measures heat flow
and temperature between a sample and reference as a function of time and
temperature. The reference is an empty hermetic aluminum pan of similar weight to
that of the sample pan. The DSC was calibrated from -100℃ to 200℃ at 5℃/min
heating rate for baseline and temperature using an indium standard.
Hydrogels were analyzed by cooling the sample from 20℃ to -80℃, and a
one minute isothermal period at -80℃, and heating the sample from -80℃ to 20℃at
5 ℃/min.

The water fractions for hydrated samples were reported as the water mass

over xerogel mass.

The total integrated area of the respective endotherm peak

represents the melting enthalpy.

The melting enthalpy was plotted as a function of
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total water fraction, and the amount of nonfreezing water was determined by the water
fraction intercept of the linear plot.

5.2.3. Method
The drug loading and releasing method are the same as previously discussed.
The equilibrium water fraction (EWF) was determined by the mass of water divided
by the mass of xerogel.
Freeze-dried were equilibrated swollen in de-ionized water, 1X PBS solution,
25mg/ml DX-21 solution at atmospheric conditions, 23℃ and 55% relative humidity.
The samples analyzed by DSC were cut from the swollen hydrogels with #1
cork bore and placed in media to reach equilibrium. For the partially hydrated samples,
some water was allowed to evaporate and then the samples were sealed in the pans to
equilibrate. The equilibrium samples were quickly weighed to ±0.01mg and
immediately analyzed by DSC. The sample mass ranged from 5 to 15mg. After DSC
analysis, the samples were removed from the hermetic pans, oven dried to obtain the
dry polymer mass. The water mass was determined by subtracting the xerogel mass
from the mass of the hydrated DSC sample.

5.3. Results and discussion
5.3.1 Equilibrium Water Fraction of Hydrogel Before and After DX-21Releae
The equilibrium water fraction of hydrogels were determined when swollen to
equilibrium in DX-21 water solution and when DX-21 loaded hydrogels released
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DX-21 completely in PBS solution at 37 ℃. This data are listed in Table 5.1.
From Figure 5.1 it can be seen that when DX-21 is released, the hydrogels
shrink. Before the release of the drug, the equilibrium water fraction of hydrogel is
more than after the release. From this it was apparent that when DX-21 is released
from the hydrogel, some water also moves out of the hydrogel and causes shrinkage.
It can be concluded that not only the composition of hydrogel, but also solutes affect
the water content of the hydrogel. Further research will focus on studying the water
structure in hydrogel at the equilibrium state in different media.
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Figure 5.1 Potos of hydrogel loaded with DX-21(A) and hydrogel released
DX-21(B)

Table 5.1 Equilibrium water fractions of DX-21 loaded hydrogels at
equilibrium before and after the release of the drug in PBS solution at 370C (means ±
SD, n=3)
EWF(with DX-21)

EWF(released DX-21)

VP15

2.91±0.17

1.49±0.11

VP30

4.25±0.09

2.17±0.23
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5.3.2 Water Structure of the HEMA-DHPMA Copolymer
HEMA-DHPMA copolymer was made by 1:1 molar ratio of HEMA and
DHPMA.

Table 5.2 shows EWFs of HEMA-DHPMA copolymer swollen in

different media.
Table 5.2 EWF and NFWF of 1HEMA:1DHPMA copolymer

sample

EWF

NFWF

water

1.7465

0.5806

PBS

1.6913

0.4814

DX-21

2.7737

0.4239

According to table 5.2 results, HEMA-DHPMA copolymer exhibits a lower
EWF in PBS solution than in deionized water.

This is different from the results

reported by other researchers (Stevenson, 1988; Gates, 2001). Stevenson found that
EWFs of polyHEMA, and poly(HEMA-co-MMA) were much higher in PBS than in
distilled water.

Gates reported that HEMA-DHPMA copolymer exhibited the same

equilibrium water content in de-ionized water as well as in saline solution.

These

results are not consistent which may imply that the equilibrium water content of
hydrogel in PBS solution depends on the gel composition and crosslink ratio.
HEMA-DHPMA copolymer imbibed more equilibrium water in the DX-21
solution than in PBS solution and de-ionized water.

This may be due to

incorporation of large molecule DX-21 which weakens the secondary bonds within
the hydrogel, enlarging the distance between the polymer chains and causing an
uptake of water.

Thus the equilibrium water content of hydrogel in DX-21 is much
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more than in PBS solution and water.

This result is similar to the above result when

DX-21 released from hydrogel along with water.
HEMA-DHPMA copolymer at equilibrium and at various states of partial
hydration was analyzed by DSC (Figure 5.2).

When hydrogels were swollen in

de-ionized water, two crystallization exotherm peaks, assigned as Tc1 at higher
temperature and Tc2 at lower temperature, are shown in cooling curves.

The

integrated area of lower temperature exotherm is greater than the higher temperature
at equilibrium in deionized water.

At initial dehydration stage, a third exotherm

peak is seen at Tc3 which is lower than Tc1 and Tc2, and both Tc1 and Tc2 are the same
as equilibrium.

When the material continued desorption, all crystallization

temperatures Tc1, Tc2 and Tc3 decreased.

These results are consistent with previous

research (G. Gates and J. Harmon, 2001).
When hydrogels were swollen in PBS solution, there is one crystallization
exotherm (Tc1) with a lower temperature shoulder at equilibrium.

The shoulder

progressively separates from the Tc1 and moved to lower temperature during
desorption.
There is only one crystallization exotherm (Tc1) at equilibrium during initial
dehydration in DX-21 solution.

Tc1 moved to lower temperature and one new

crystallization peak (Tc2) appeared when dehydration process continued.
In summary, the crystallization of water inside the hydrogel appears to be
dependent of the water fraction of hydrogel.
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At high water fraction, only one

transition peak is present, and more transitions appear as water fraction decreases.
At higher water fractions, there is only one sharp peak indicating the perfect
crystallization of water. With lower water fraction, one or two more crystallizing
peaks appeared.

The reduced swelling and shrinkage during the process of

dehydration can restrict the mobility of the water due to stronger interactions with
polymer or water.

This makes it harder to form perfect crystals, so broader peaks

appeared in lower temperatures instead of sharp peaks.
There are two transitions observed in the heating curves at different water
fractions when HEMA-DHPMA copolymer is swollen in water and PBS solution.
The temperature Tm1 (transition near 273K) was assigned for free freezing water, and
temperature Tm2 for freezable bound water (transition near 263K) (Ahmad and
Huglin ,1994).

From the transitions of different water fractions swollen in DX-21, it

can be seen that when EWF is over 2.36, the two peaks merge progressively to
become a broad peak. Such a broad endothermic peak was also observed in other
hydrophilic polymers (Ping et al. 2001;Wycisk and Trochimczuk,1992;Tasaka et al.
1988;Zhang et al. 1989;Fushimi et al. 1991;Hatada et al. 1982)
Ahmad M. B. reported that the appearance of the second transition at Tm2
seemed to be dependent of the amount of water absorbed by the hydrogels while there
is no evidence for Tm1 to deviating from 273 K.

Ping reported that the melting point

of freezable bound water increased linearly with the water content in PVA hydrogels
and explained that the lowering of the freezable bound water melting point was due to
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the increase in the overall hydrogen bonding ability of the polymer (Ping et al. 2001).
Baker reported that the thermal transition temperature for free freezing water was
found to decrease with decreasing water content (Fushimi et al. 1991).

For the

present results, both peak maximum temperatures Tm1 and Tm2 decreased with
decreasing water fraction.

These heating results are consistent with our cooling

results, because in the cooling process imperfect ice crystals formed during the
dehydration process, were unstable compared to the perfect crystals and melt at lower
temperatures.
A decrease in separation (Tm1-Tm2) of peak maximum temperatures with
increasing EWC has been reported by (Higuchi and Iijima,1985), but the separation
did not decrease consistently with increasing EWC was also reported by Ahmad M. B.
(Ahmad,1994).

These reports were not in agreement with each other, which may be

due to different polymer compositions with different EWC.

In present study, the

separation was studied based on the same formulation with different water contents.
The results showed that separation (Tm1-Tm2) (Table 5.3) increased with increasing
water fraction contrary to what was reported by Higuchi (Higuchi and Iijima,1985).

109

Table 5.3 Water melting points of hydrogels at different water fractions

WF

Tm1(℃)

Tm2(℃)

Tm1-Tm2

VP0(water)

1.74

5.62

-5.13

10.75

VP0-1(water)

1.58

3.45

-5.67

9.12

VP0-2(water)

1.20

2.03

-5.84

7.87

VP0-3(water)

0.88

-0.22

-6.13

5.91

VP0(PBS)

1.69

3.06

VP0-1(PBS)

1.51

3.14

-7.63

10.77

VP0-2(PBS)

1.41

1.84

-8.15

9.99

VP0-3(PBS)

1.27

0.61

-8.67

9.28

VP0-4(PBS)

0.89

-0.22

-8.93

8.71

VP0(DX21)

2.77

6.49

VP0-1(DX21)

2.36

4.96

VP0-2(DX21)

1.62

2.96

-6.20

9.16

VP0-3(DX21)

1.14

VP0-4(DX21)

0.81

-7.64
-0.24
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-8.37

8.13
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Figure 5.2 DSC cooling and heating curves for 1HEMA:1DHPMA copolymer at
various stages during desorption of deionized water, PBS solution and DX-21
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Since the nonfreezing water fraction can be defined as the limiting value of
water fraction at zero enthalpy of fusion (Vaquez et al. 1997), the enthalpy (integrated
area) of melting endotherms from the DSC data was used to determine the
nonfreezing water fraction by extrapolation.

Linear plots of the total endotherm area

as a function of water fraction are presented in figure 5.3, 5.4, 5.5.

The water

fraction intercept was used as the fraction of nonfreezing water (NFWF) and shown in
Table 5.2.

This is different from Gates’s result which reports that nonfreezing water

fractions in water and PBS solution are almost the same. This may be due to different
PBS solution and different crosslink ratio of 1HEMA:1DHPMA copolymer.
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Figure 5.3 Linear plot of total integrated endotherm area versus total water fraction
for the 1 HEMA:1 DHPMA copolymer swollen in deionized water

Figure 5.4 Linear plot of total integrated endotherm area versus total water fraction
for the 1 HEMA:1 DHPMA copolymer swollen in PBS solution

Figure 5.5 Linear plot of total integrated endotherm area versus total water
fraction for the 1 HEMA:1 DHPMA copolymer swollen in DX-21 solution
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5.3.3. Water Structure of VP-HEMA-DHPMA Copolymer Hydrogels
Based on 1HEMA:1DHPMA copolymer, different molar ratios (15, 30, 45) of
VP were copolymerized with 1HEMA:1DHPMA monomers to obtain
VP-HEMA-DHPMA copolymer, VP15, VP30, VP45.

Equilibrium water fractions of

VP15, VP30 and VP45 were determined by mass of water divided by mass of xerogel
and listed in Table 5.4.

Water structures of VP-HEMA-DHPMA copolymer swollen

in de-ionized water, PBS solution and DX-21 solution were studied by DSC.

Linear

plots of the total endotherm area as a function of water fraction are presented in figure
5.6, 5.7, 5.8.

The water fraction intercept was used as the fraction of nonfreezing

water (NFWF) and shown in Table 5.6.

Freezing water fraction was determined by

subtracting nonfreezing water fraction from equilibrium water fraction (Table5.7).
All VP-HEMA-DHPMA copolymers exhibited highest equilibrium water
fractions in DX-21 and lowest in PBS solution. This result is the same as the
1HEMA:1DHPMA copolymer.

The low equilibrium water content of hydrogel is

usually improved by copolymerizing more hydrophilic monomers.

It seems that

large water soluble salts such as DX-21 also can increase the equilibrium water
content of hydrogel.
Table 5.5 shows values of the difference of water mass between the hydrogels
at equilibrium in DX-21 and PBS solution divided by mass of DX-21 loaded in
hydrogel.

For DX-21 all values are about 9.6 which is independent of polymer

compositions. This offers a new and simple method to estimate the drug loading
amount in hydrogels.
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Table 5.4 EWF of VP-HEMA-DHPMA copolymer

sample

PBS

water

DX-21

VP15

1.6947

1.8122

2.8036

VP30

1.8709

2.0100

2.9346

VP45

1.8890

2.2428

3.1004

Table 5.5 Vlues of Δwater mass(g) / DX-21mass(g)

Δwater mass(g) /

Hydrogel

DX-21mass(g)
VP15

9.6

VP30

9.6

VP45

9.6
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Figure 5.6 Linear plot of total integrated endotherm area versus total water
fraction for the VP15 copolymer swollen in water, PBS and DX-21 solution
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Figure 5.7 Linear plot of total integrated endotherm area versus total water
fraction for the VP15 copolymer swollen in water, PBS and DX-21 solution
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Figure 5.8 Linear plot of total integrated endotherm area versus total water
fraction for the VP15 copolymer swollen in water, PBS and DX-21 solution
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Table 5.6 NFWF of VP-HEMA-DHPMA copolymer

sample

PBS

water

DX-21

VP15

0.4581

0.4120

0.4756

VP30

0.4291

0.3791

0.4798

VP45

0.4301

0.3186

0.5112

Table 5.7 FWF of VP-HEMA-DHPMA copolymer

sample

PBS

water

DX-21

VP15

1.2366

1.4002

2.3280

VP30

1.4418

1.6309

2.4548

VP45

1.4589

1.9242

2.5892

When the hydrogels are at equilibrium in PBS solution and water,
non-freezing water content decreased with the increase of the VP content even though
the whole water content increase. A similar decrease has also been found for the
poly(VP-MMA) hydrogels (Liu and Huglin, 1995). Liu tried to explain that the
decrease of nonfreezing water content was due to the increase of water content
according to different swelling time. This was an obvious fact because the same
formulation swells at different time when nonfreezing water content is expressed
relative to the mass of the hydrogel. However, this explanation is not reasonable when
nonfreezing water content is expressed relative to the mass of xerogel. This
explanation also does not explain the relation of the nonfreezing water content and VP
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content, thus there is no definitive explanation for this trend. However, following are
two possible explanations.
One explanation for the observed trend may be that when VP content
increased, more H-bond formed between the polymer chains as evident by the
increase of the glass transition temperature (chapter 3). Since nonfreezing water is the
H-bond water formed between water and polymer chain, the inter-chain H-bond
reduced the total available sites to form H-bond with water molecules. Thus, the
amount of non-freezing bond water decreases with increasing VP content.
Another possible explanation for present polymers is that different average
number of non-freezing water molecules per site. From the following table, it can be
seen that average number of non-freezing water molecules per VP is 4.2, per HEMA
is 4.1 and per DHPMA is 6.4. Since the molar ratio of HEMA and DHPMA is 1:1, so
the average number of non-freezing water molecules per (HEMA-DHPMA) is 5.25
which is larger than VP. Thus when VP content increased, the number of non-freezing
water molecules decreased which lead to the decrease of nonfreezing water content.
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Table 5.8 Molar ratios of non-freezing bound water in different polymers

polymers

Nnf/Np

PVP*

4.2

PHEMA*

4.1

PDHPMA*

6.4

*PHEMA and PDHPMA results were calculated from the reference (Gates and
Harmon, 2001)
*PVP result was obtained from the reference (Ping et al. 2001)
From table 5.6 it also can be seen that all VP contained samples showed higher
nonfreezing water content in PBS solution than in de-ionized water which is different
from 1HEMA:1DHPMA copolymer.

Without VP, the salt ions interfere with the OH

groups on the polymer chain thereby reducing the number of H-bonding sites
available to water. VP in the polymer chain blocks the salts from interfering with the
H-bonding sites thus allowing water to H-bond with the polymer. Thus more
H-bonding sites are created and higher nonfreezing water content was seen.
When VP contained gels were swollen to reach equilibrium in DX-21,
hydrogels exhibited more FWF and NFWF than in de-ionized water and PBS solution.
The additional nonfreezing water content could be from H-bonding water with the
DX-21 since DX-21 molecules contain polar groups such as O, F, and OH.

When

more DX-21 molecules entered into the polymer matrix, they also bring in more free
water to the matrix.

The incorporation of large DX-21 molecules can strengthen the

distance of the polymer chain and let more freezable water enter into the matrix.
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5.4. Conclusion
Equilibrium water fraction of drug loaded hydrogel is bigger than that of drug
released hydrogel, which is confirmed by the shrinkage of hydrogel.

This result

implies that both the composition of the hydrogel and the solutes can affect the water
structure.
1HEMA:1DHPMA copolymer and VP-HEMA-DHPMA copolymers imbibed
highest equilibrium water fraction in DX-21 solution, lowest equilibrium water
fraction in PBS solution.

During dehydration process, crystallization exotherms and

melting endotherms of 1HEMA:1 DHPMA copolymer in all different media moved to
lower temperatures due to the shrinkage of hydrogel causeing imperfect ice crystals to
form, and a decrease in separation (Tm1-Tm2).
For VP-HEMA-DHPMA copolymer, the non-freezing water fraction decreases
with an increase of VP at equilibrium state in water and PBS solution even though the
equilibrium water fraction increased.

This trend is explained by the decrease of

H-bond sites with water and less molar ratio of nonfreezing water per molecule when
compared to 1HMEA:1DHPMA. Both non-freezing water fraction and freezing water
fraction of VP contained hydrogels are higher in DX-21 solution than in PBS and
water.

The information offers a new way to increase the low water content hydrogel

by swelling xerogels in media containing large water soluble molecules.

Since

DX-21 molecules contain polar groups such as OH, F and O, it can bring some
H-bond water into the matrix. When the distance between the polymer chains is
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increased, more free water will be incorporated.
Since the ratio of transporting water mass to DX-21 mass is 9.6 which is
independent of hydrogel compositions, the DX-21 load can also be estimated by the
difference of equilibrium water content of hydrogel swollen in DX-21 solution and
PBS solution.
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CHAPTER 6
SUMMARY AND SUGGESTIONS FOR FUTURE STUDY
6.1. Summary
State of the art implantable glucose sensors do not work reliably and have a
rather short life after implantation (Moussy, 2002). This in vivo loss of function is
caused by tissue reactions surrounding the sensor such as fibrosis and inflammation
(Mang et al, 2005).

It is believed that the performance of implanted glucose sensors

can greatly benefit from the use of more biocompatible outer most coatings.
Therefore, in order to improve the lifetime of implantable glucose sensors, two
different novel series of hydrogel coatings were designed, synthesized and
characterized for use on implantable glucose sensors.
During this effort novel hydrogel polymers with various DHPMA content
were prepared, characterized, and coated onto implantable glucose sensors and then
tested in vitro and in vivo.

The effects of 2,3-dihydroxypropyl methacrylate

(DHPMA) on the swelling, morphology, glass transition(Tg), and water structure were
studied.

The results show that the degree of swelling increases with increasing

DHPMA content.

Scanning electron microscopy (SEM) studies identified uniform,

porous structures in samples containing 60-90 mole % DHPMA.

Glass transition

temperatures did not change significantly with DHPMA content, but the ratio of
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freezing to nonfreezing water tended to increase with DHPMA content.

Sensors

coated with different hydrogels were prepared and in vitro evaluations were
performed.

The 80% DHPMEA hydrogels exhibited optimum sensitivity, response

and stability when coated directly onto the sensor or top of a polyurethane (PU) layer.
The histology results show that 80% DHPMA samples exhibit reduced fibrosis and
inflammation.

Eight D80 coated Pt/GOX/epoxy-polyurethane glucose sensors were

implanted into 4 rats (2 sensors/rat).

The original attempt of in vivo implanted

glucose sensors was not successful, because only 25% of the sensors were working at
4 weeks.

In order to further improve the efficiency of implanted glucose sensors,

another series of novel hydrogels were developed based on copolymer of HEMA and
DHPMA.

The porosity and mechanical properties of the hydrogels were improved

using VP and EGDMA. The results of SEM, DSC, and FT-IR analysed show that the
hydrogel (VP30) produced from a monomeric mixture of 69% (1HEMA:1DHPMA),
30% VP and 1% EDGMA (mol%) had a more uniform pore structure and net structure,
high water content at swelling equilibrium (EWF = 166% by mass) and acceptable
mechanical properties.

Two kinds of VP30-coated sensors, Pt/GOx/VP30 and

Pt/GOx/epoxy-polyurethane (EPU)/VP30 sensors were examined in glucose solutions
during a period of 4 weeks.

The Pt/GOx/VP30 sensors produce large response

currents but the response linearity was poor.

Therefore, further studies were focused

on the Pt/GOx/EPU/VP30 sensors. With a diffusion-limiting epoxy-polyurethane
membrane, the linearity was improved (2–30 mM) and the response time was within 5
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min.

Eight Pt/GOx/EPU/VP30 sensors were subcutaneously implanted in rats and

tested once per week over 4 weeks.

All of the implanted sensors kept functioning

for at least 21 days and 3 out of 8 sensors still functioned at day 28.

Histology

revealed that the fibrous capsules surrounding hydrogel-coated sensors were thinner
than those surrounding Pt/GOx/EPU sensors after 28 days of implantation.
It was discussed that the biocompatibility of glucose sensors was improved by
hydrogel.

However, there is still a small amount of inflammation and fibrosis

occuring within the tissue around the implanted glucose sensors after 4 weeks.
According to recent reports (Norton et al, 2006; Patil et al, 2004; Yoon et al,2003;
Klueh et al, 2007), the local release of DX can suppress the acute inflammation
around the biosensors and may improve biocompatibility and prolong sensor lifetime.
In order to further suppress the biofouling process, Dexamethasone-21 phosphate
disodium salt (DX-21) was incorporated to the hydrogel to do the targeted drug
delivery research.

DX-21 was successfully loaded into a series of hydrogels by

equilibrium partitioning.

The drug release kinetics shows that DX-21 releasing

mechanism from novel hydrogels is Fickian diffusion.

The factors influence drug

releasing behavior is relative to drug uptaking behavior: concentration gradient,
inner-morphology and water content which are decided by polymer composition.
All hydrogels showed a high initial release, followed by slow, long term release
during the next hours to days.

This function is believed to be good for the implanted

glucose sensors to suppress the acute inflammation and chronic inflammation.
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During the release experiment, some DX-21(Figure4.1) molecules convert to
DX (Figure 4.2). Different mobile phases have been developed to determine DX-21
and DX separately (Blackford et al, 2000). It was too costly and time consuming to
use different mobile phase to detect DX and DX-21 separately; therefore, a single
mobile phase methanol:water=6:4(0.01MKH2PO4) that could be used to detect both
was created.
The structure of water in the hydrogel can determine the biocompatibility of
the hydrogel and affect the transportation of the molecules between the matrix and
intermediate.

The investigations on the structure of water in a polymer can give

valuable information on the sorption, diffusion and permeation properties of
molecular species in hydrophilic polymers (Ping et al. 2001). The water structure in
hydrogels swollen in different media including water, PBS and DX-21 solution were
investigated. Results show that equilibrium water fraction of drug loaded hydrogel
is larger than that of drug released hydrogel, which is confirmed by the shrinkage of
hydrogel.

This result implied both the composition of hydrogel and solutes can

affect the water structure in the hydrogel.
1HEMA:1DHPMA copolymer and VP-HEMA-DHPMA copolymers imbibed
highest equilibrium water fraction in DX-21 solution, lowest equilibrium water
fraction in PBS solution.

This information offers a new way to increase the low

water content of hydrogel by swelling xerogels in large water soluble molecules
media.

Since the ratio of transporting water mass to DX-21 mass is 9.6 which is
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independent of the hydrogel composition, the DX-21 load can be estimated by the
difference of equilibrium water content of hydrogel swells in DX-21 solution and PBS
solution.
During dehydration process, crystallization exotherms and melting endotherms
of 1HEMA:1 DHPMA copolymer in all the different media moved to lower
temperatures due to the shrinkage of hydrogel which causes imperfect ice crystals, at
the same time separation (Tm1-Tm2) decreased too.
For VP-HEMA-DHPMA copolymer, the non-freezing water fraction decreases
with VP increases at equilibrium state in water and PBS solution even though the
equilibrium water fraction increases.

This trend is explained by the decrease of

H-bond sites with water and less molar ratio of nonfreezing water per molecule.
Both non-freezing water fraction and freezing water fraction of VP contained
hydrogels are higher in DX-21 solution than in PBS and water.

6.2. Suggestions for Future Works
The efficiency of implanted glucose sensors has been enhanced by novel
hydrogel coatings.

However, there is still some inflammation processes and fibrosis

that occurs to the tissue around implanted glucose sensor. The drug delivery in vitro
study shows that DX-21 loaded hydrogel should effectively suppress acute
inflammation and chronic inflammation. In a future study, drug loaded hydrogel
coated glucose sensors will be implanted into rats and determine the performance of
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the implanted glucose sensors.
It has been reported that controlled neovascularization around sensor by
angiogenic growth factors such as VEGF can improve the performance of implanted
glucose sensors (Klueh et al.2003,2005).

The pores structures inside the hydrogel

can be useful for locating nanoparticles or microspheres for controlled drug release
system. The future goal of more studies will be to incorporate VEGF loaded
microspheres or nanoparticles to these novel pores matrix.

At last a dual release

system for both DX-21 in the hydrogel and VEGF in microspheres will be realized.
It has been reported that DX can lead to an anti-angiogenesis effect along with an
anti-inflammatory response.

The initial burse release of DX-21 from this new dual

release system can suppress the acute inflammation.

VEGF will be released slowly

form microspheres and nanoparticle accompanied by low level release of DX-21
which can not greatly affect the angiogenesis.
Since these novel hydrogel coatings improved the biocompatibility of
implanted glucose sensors, they have the potential use for other implantable
biosensors.

A future study can also be focused on the modification of these novel

hydrogel coatings for other implantable biosensors.
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Appendix A: Chapter 2, DSC curves

Figure A-1.DSC curve for glass transition of D0 sample

Figure A-2. DSC curve for glass transition of D20 sample

147

Appendix A (continued)

Figure A-3. DSC curve for glass transition of D40 sample

Figure A-4. DSC curve for glass transition of D60 sample
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Appendix A (continued)

Figure A-5. DSC curve for glass transition of D80 sample

Figure A-6. DSC curve for glass transition of D90 sample
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Appendix A (continued)

Figure A-7. DSC curve for water structure of D0 with 48.8% EWC

Figure A-8. DSC curve for water structure of D20 with 52.0% EWC
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Appendix A (continued)

Figure A-9. DSC curve for water structure of D40 with 60.1% EWC

Figure A-10. DSC curve for water structure of D60 with 65.5%
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Appendix A (continued)

Figure A-11. DSC curve for water structure of D80 with 69.4% EWC

Figure A-12. DSC curve for water structure of D90 with 69.9% EWC
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Appendix B: Chapter 5

Figure B-1 DSC curve for water structure of VP15 swollen in water with 1.8122 EWF

Figure B-2 DSC curve for water structure of VP15 swollen in water with 1.6144 EWF
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Appendix B (Continued)

Figure B-3 DSC curve for water structure of VP15 swollen in water with 1.3636 EWF

Figure B-4 DSC curve for water structure of VP15 swollen in water with 1.0245 EWF
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Appendix B (Continued)

Figure B-5 DSC curve for water structure of VP15 swollen in water with 0.5908 EWF

Figure B-6 DSC curve for water structure of VP15 swollen in PBS with 1.6947 EWF
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Appendix B (Continued)

Figure B-7 DSC curve for water structure of VP15 swollen in PBS with 1.3817 EWF

Figure B-8 DSC curve for water structure of VP15 swollen in PBS with 1.0981 EWF
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Appendix B (Continued)

Figure B-9 DSC curve for water structure of VP15 swollen in DX-21 with 2.8036
EWF

Figure B-10 DSC curve for water structure of VP15 swollen in DX-21 with 2.3937
EWF
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Appendix B (Continued)

Figure B-11 DSC curve for water structure of VP15 swollen in DX-21 with 1.3192
EWF

Figure B-12 DSC curve for water structure of VP15 swollen in DX-21 with 2.0100
EWF
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Appendix B (Continued)

Figure B-13 DSC curve for water structure of VP30 swollen in water with 1.6053
EWF

Figure B-14 DSC curve for water structure of VP30 swollen in water with 1.0348
EWF
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Appendix B (Continued)

Figure B-15 DSC curve for water structure of VP30 swollen in water with 0.8266
EWF

Figure B-16 DSC curve for water structure of VP30 swollen in water with 0.5072
EWF
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Appendix B (Continued)

Figure B-17 DSC curve for water structure of VP30 swollen in PBS with 1.8709 EWF

Figure B-18 DSC curve for water structure of VP30 swollen in PBS with 1.5754 EWF
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Appendix B (Continued)

Figure B-19 DSC curve for water structure of VP30 swollen in PBS with 1.1570 EWF

Figure B-20 DSC curve for water structure of VP30 swollen in PBS with0.9071 EWF
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Appendix B (Continued)

Figure B-21 DSC curve for water structure of VP30 swollen in PBS with 0.6337 EWF

Figure B-22 DSC curve for water structure of VP30 swollen in DX-21 with 2.9346
EWF
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Appendix B (Continued)

Figure B-23 DSC curve for water structure of VP30 swollen in DX-21 with 2.3633
EWF

Figure B-24 DSC curve for water structure of VP30 swollen in DX-21 with 1.5244
EWF
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Appendix B (Continued)

Figure B-25 DSC curve for water structure of VP30 swollen in DX-21 with 1.1222
EWF

Figure B-26 DSC curve for water structure of VP30 swollen in DX-21 with 0.7178
EWF
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Appendix B (Continued)

Figure B-27 DSC curve for water structure of VP45 swollen in water with 2.2428
EWF

Figure B-28 DSC curve for water structure of VP45 swollen in water with 1.5505
EWF
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Appendix B (Continued)

Figure B-29 DSC curve for water structure of VP45 swollen in water with 1.2132
EWF

Figure B-30 DSC curve for water structure of VP45 swollen in water with 0.8414
EWF
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Appendix B (Continued)

Figure B-31 DSC curve for water structure of VP45 swollen in PBS with 1.8890 EWF

Figure B-32 DSC curve for water structure of VP45 swollen in PBS with 1.6677 EWF
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Appendix B (Continued)

Figure B-33 DSC curve for water structure of VP45 swollen in PBS with 1.3592 EWF

Figure B-34 DSC curve for water structure of VP45 swollen in PBS with 1.2318 EWF
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Appendix B (Continued)

Figure B-35 DSC curve for water structure of VP45 swollen in PBS with 0.7746 EWF

Figure B-36 DSC curve for water structure of VP45 swollen in DX-21 with 3.1004
EWF
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Appendix B (Continued)

Figure B-37 DSC curve for water structure of VP45 swollen in DX-21 with 2.1888
EWF

Figure B-38 DSC curve for water structure of VP45 swollen in DX-21 with 2.1169
EWF
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Appendix B (Continued)

Figure B-39 DSC curve for water structure of VP45 swollen in DX-21 with 1.8013
EWF
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